CDK9
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0A2R8Y4L2 | S95 | Sugiyama | HNRNPA1L3 HNRNPA1P48 | RPHKVDGRVVEPKRAVSREDsQRPDAHLTVKKIFVGGIKED |
| O00115 | S70 | Sugiyama | DNASE2 DNASE2A DNL2 | QYKyLDEssGGWRDGRALINsPEGAVGRSLQPLyRSNTSQL |
| O00165 | S153 | Sugiyama | HAX1 HS1BP1 | PDSHQPRIFGGVLESDARSEsPQPAPDWGsQRPFHRFDDVW |
| O00178 | S12 | Sugiyama | GTPBP1 | _________MATERsRsAMDsPVPAsMFAPEPssPGAARAA |
| O00178 | S6 | Sugiyama | GTPBP1 | _______________MATERsRsAMDsPVPAsMFAPEPssP |
| O00178 | S8 | Sugiyama | GTPBP1 | _____________MATERsRsAMDsPVPAsMFAPEPssPGA |
| O00193 | S17 | Sugiyama | SMAP C11orf58 | ____MsAARESHPHGVKRsAsPDDDLGssNWEAADLGNEER |
| O00267 | S666 | EPSD|PSP | SUPT5H SPT5 SPT5H | AGGSKPRDVtNFtVGGFAPMsPRIssPMHPSAGGQRGGFGs |
| O00267 | S773 | PSP | SUPT5H SPT5 SPT5H | VGsRRPGGMTsTYGRtPMYGsQtPMYGsGsRtPMYGsQtPL |
| O00267 | S782 | PSP | SUPT5H SPT5 SPT5H | TsTYGRtPMYGsQtPMYGsGsRtPMYGsQtPLQDGsRtPHy |
| O00267 | T768 | SIGNOR|EPSD|PSP | SUPT5H SPT5 SPT5H | QRLTTVGsRRPGGMTsTYGRtPMYGsQtPMYGsGsRtPMYG |
| O00267 | T775 | GPS6|SIGNOR|EPSD|PSP | SUPT5H SPT5 SPT5H | sRRPGGMTsTYGRtPMYGsQtPMYGsGsRtPMYGsQtPLQD |
| O00267 | T784 | GPS6|SIGNOR|EPSD|PSP | SUPT5H SPT5 SPT5H | TYGRtPMYGsQtPMYGsGsRtPMYGsQtPLQDGsRtPHyGs |
| O00267 | T791 | SIGNOR|EPSD|PSP | SUPT5H SPT5 SPT5H | YGsQtPMYGsGsRtPMYGsQtPLQDGsRtPHyGsQtPLHDG |
| O00267 | T799 | SIGNOR|EPSD|PSP | SUPT5H SPT5 SPT5H | GsGsRtPMYGsQtPLQDGsRtPHyGsQtPLHDGsRtPAQsG |
| O00267 | T806 | SIGNOR|EPSD|PSP | SUPT5H SPT5 SPT5H | MYGsQtPLQDGsRtPHyGsQtPLHDGsRtPAQsGAWDPNNP |
| O00267 | T814 | SIGNOR|EPSD|PSP | SUPT5H SPT5 SPT5H | QDGsRtPHyGsQtPLHDGsRtPAQsGAWDPNNPNtPsRAEE |
| O14545 | S327 | Sugiyama | TRAFD1 FLN29 | DHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQQAAS |
| O14545 | T323 | Sugiyama | TRAFD1 FLN29 | ELLIDHQTSCNPSRALPsLNtGsssPRGVEEPDVIFQNFLQ |
| O14979 | S241 | Sugiyama | HNRNPDL HNRPDL JKTBP | KRAKALKGKEPPKKVFVGGLsPDtsEEQIKEYFGAFGEIEN |
| O15047 | S470 | Sugiyama | SETD1A KIAA0339 KMT2F SET1 SET1A | sPEREEVRtsPRPAsPARsGsPAPEttNESVPFAQHSSLDS |
| O15085 | S1295 | Sugiyama | ARHGEF11 KIAA0380 | PEQEDMGLCSLEHLPPRtRNsGIWEsPELDRNLAEDASSTE |
| O43237 | S194 | Sugiyama | DYNC1LI2 DNCLI2 LIC2 | ERKFVKDFQDyMEPEEGCQGsPQRRGPLtsGsDEENVALPL |
| O43765 | S77 | Sugiyama | SGTA SGT SGT1 | TLPEIFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTE |
| O43765 | S84 | Sugiyama | SGTA SGT SGT1 | AAATGKEMPQDLRsPARtPPsEEDsAEAERLKTEGNEQMKV |
| O43765 | T81 | Sugiyama | SGTA SGT SGT1 | IFEAAATGKEMPQDLRsPARtPPsEEDsAEAERLKTEGNEQ |
| O43852 | S261 | Sugiyama | CALU | RDKNRDGKMDKEEtKDWILPsDyDHAEAEARHLVyEsDQNK |
| O43852 | T65 | Sugiyama | CALU | FDyDHDAFLGAEEAKtFDQLtPEEsKERLGKIVSKIDGDKD |
| O60239 | S375 | Sugiyama | SH3BP5 SAB | LsEFGMMFPVLGPRsECsGAssPECEVERGDRAEGAENKTS |
| O60292 | S158 | Sugiyama | SIPA1L3 KIAA0545 SPAL3 | FHRLSRRRsKDVEFQDGWPRsPGRAFLPLRHRsssEItLSE |
| O60563 | S352 | Sugiyama | CCNT1 | KRWLSSQPsFKLEPTQGHRtsENLALtGVDHsLPQDGsNAF |
| O60563 | S363 | Sugiyama | CCNT1 | LEPTQGHRtsENLALtGVDHsLPQDGsNAFISQKQNSKSVP |
| O60563 | S369 | Sugiyama | CCNT1 | HRtsENLALtGVDHsLPQDGsNAFISQKQNSKSVPSAKVSL |
| O60563 | S427 | Sugiyama | CCNT1 | LENMEANVKSQYAyAAQNLLsHHDsHsSVILKMPIEGsENP |
| O60563 | S431 | Sugiyama | CCNT1 | EANVKSQYAyAAQNLLsHHDsHsSVILKMPIEGsENPERPF |
| O60563 | S433 | Sugiyama | CCNT1 | NVKSQYAyAAQNLLsHHDsHsSVILKMPIEGsENPERPFLE |
| O60563 | S444 | Sugiyama | CCNT1 | NLLsHHDsHsSVILKMPIEGsENPERPFLEKADKTALKMRI |
| O60563 | S577 | Sugiyama | CCNT1 | KTYSLSssFsSSsSTRKRGPsEEtGGAVFDHPAKIAKSTKS |
| O60563 | T216 | Sugiyama | CCNT1 | VACVCIHLACKWSNWEIPVStDGKHWWEYVDATVTLELLDE |
| O60563 | T358 | Sugiyama | CCNT1 | QPsFKLEPTQGHRtsENLALtGVDHsLPQDGsNAFISQKQN |
| O60563 | T580 | Sugiyama | CCNT1 | SLSssFsSSsSTRKRGPsEEtGGAVFDHPAKIAKSTKSSSL |
| O60563 | Y420 | Sugiyama | CCNT1 | LAAQKRQLENMEANVKSQYAyAAQNLLsHHDsHsSVILKMP |
| O60583 | T215 | Sugiyama | CCNT2 | IACVCIHLACKWSNWEIPVStDGKHWWEYVDPTVTLELLDE |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75131 | S240 | Sugiyama | CPNE3 CPN3 KIAA0636 | DGSHDLIGTFQTTMTKLKEAsRssPVEFECINEKKRQKKKS |
| O75533 | T223 | Sugiyama | SF3B1 SAP155 | tADQtPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsE |
| O75533 | T227 | Sugiyama | SF3B1 SAP155 | tPGAtPKKLssWDQAEtPGHtPsLRWDEtPGRAKGsEtPGA |
| O75533 | T313 | Sugiyama | SF3B1 SAP155 | WDEtPKtERDtPGHGsGWAEtPRtDRGGDsIGEtPtPGAsK |
| O75828 | S56 | Sugiyama | CBR3 SDR21C2 | TARDVARGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| O75909 | S36 | Sugiyama | CCNK CPR4 | NLDHTKPCWYWDKKDLAHTPsQLEGLDPATEARYRREGARF |
| O76080 | S61 | Sugiyama | ZFAND5 ZA20D2 ZNF216 | QQNsGRMsPMGtAsGsNsPtsDSASVQRADtsLNNCEGAAG |
| O94826 | S91 | Sugiyama | TOMM70 KIAA0719 TOM70 TOMM70A | RGDASGLKRNSERKtPEGRAsPAPGsGHPEGPGAHLDMNsL |
| O94842 | S178 | Sugiyama | TOX4 C14orf92 KIAA0737 | GGGTILPPAQSPEDRLsttPsPtssLHEDGVEDFRRQLPSQ |
| O94979 | S188 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | PEDISCIAWNRQVQHILAsAsPsGRATVWDLRKNEPIIKVS |
| O94979 | S799 | Sugiyama | SEC31A KIAA0905 SEC31L1 HSPC275 HSPC334 | IMQLRDRLCRAQGEPVAGHEsPKIPyEKQQLPKGRPGPVAG |
| O95149 | S350 | Sugiyama | SNUPN RNUT1 SPN1 | ENGHyELEHLstPKLKGssHsPDHPGCLMEN__________ |
| O95155 | S88 | Sugiyama | UBE4B HDNB1 KIAA0684 UFD2 | GASGVAHRsQssEGVssLsssPsNsLEtQsQsLsRsQsMDI |
| O95359 | S2317 | Sugiyama | TACC2 | MPLRRPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTF |
| O95359 | S2321 | Sugiyama | TACC2 | RPKMKKtPEKLDNtPAsPPRsPAEPNDIPIAKGTYTFDIDK |
| O96019 | S195 | PSP | ACTL6A BAF53 BAF53A INO80K | THTTAIPVHDGYVLQQGIVKsPLAGDFITMQCRELFQEMNI |
| O96019 | S233 | PSP | ACTL6A BAF53 BAF53A INO80K | MNIELVPPYMIASKEAVREGsPANWKRKEKLPQVTRSWHNY |
| O96019 | S86 | PSP | ACTL6A BAF53 BAF53A INO80K | PtyyIDtNALRVPRENMEAIsPLKNGMVEDWDSFQAILDHT |
| P00558 | T168 | Sugiyama | PGK1 PGKA MIG10 OK/SW-cl.110 | EAFRAsLSKLGDVyVNDAFGtAHRAHssMVGVNLPQKAGGF |
| P02545 | S390 | Sugiyama | LMNA LMN1 | DMEIHAYRKLLEGEEERLRLsPsPtsQRsRGRAssHssQtQ |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04406 | T211 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | PsGKLWRDGRGALQNIIPAstGAAKAVGKVIPELNGKLtGM |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04637 | S315 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | PHHELPPGStKRALPNNTsssPQPKKKPLDGEyFTLQIRGR |
| P04637 | S33 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | PLsQEtFsDLWKLLPENNVLsPLPsQAMDDLMLsPDDIEQW |
| P04637 | S392 | GPS6|SIGNOR|iPTMNet|EPSD|PSP | TP53 P53 | KKGQstsRHKKLMFKtEGPDsD___________________ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S177 | Sugiyama | ALPP PLAP | RAKKAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADVP |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S17 | Sugiyama | RPLP2 D11S2243E RPP2 | ____MRyVAsyLLAALGGNssPsAKDIKKILDsVGIEADDD |
| P06400 | S795 | EPSD|PSP | RB1 | RPPtLsPIPHIPRsPyKFPssPLRIPGGNIyIsPLKsPYKI |
| P06400 | S807 | EPSD|PSP | RB1 | RsPyKFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtP |
| P06400 | S811 | EPSD|PSP | RB1 | KFPssPLRIPGGNIyIsPLKsPYKIsEGLPtPtKMtPRSRI |
| P06733 | S263 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GMDVAASEFFRsGKyDLDFKsPDDPsRyIsPDQLADLyKsF |
| P06744 | S455 | Sugiyama | GPI | ALMRGKSTEEARKELQAAGKsPEDLERLLPHKVFEGNRPTN |
| P07195 | S303 | Sugiyama | LDHB | GIENEVFLSLPCILNARGLtsVINQKLKDDEVAQLKKsADt |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07205 | T168 | Sugiyama | PGK2 PGKB | EAFRAsLSKLGDVyVNDAFGtAHRAHSSMVGVNLPHKASGF |
| P07437 | S168 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| P07437 | S172 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | ISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSVHQL |
| P07437 | T166 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | GMGTLLISKIREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S885 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | KEKTGKEyIPGQPPLsQssDssPtRNsEPAGLEtPEAKVLF |
| P07858 | S216 | Sugiyama | CTSB CPSB | PPCTGEGDTPKCSKICEPGysPtyKQDKHYGYNSYSVSNSE |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P08195 | S607 | Sugiyama | SLC3A2 MDU1 | ASLPAKADLLLstQPGREEGsPLELERLKLEPHEGLLLRFP |
| P08865 | T97 | Sugiyama | RPSA LAMBR LAMR1 | IssRNtGQRAVLKFAAAtGAtPIAGRFtPGTFTNQIQAAFR |
| P09651 | S95 | Sugiyama | HNRNPA1 HNRPA1 | RPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| P09923 | S174 | Sugiyama | ALPI | RAKQAGKSVGVVTTTRVQHAsPAGtyAHtVNRNWysDADMP |
| P09972 | S132 | Sugiyama | ALDOC ALDC | GVVPLAGtDGEtttQGLDGLsERCAQYKKDGADFAKWRCVL |
| P10275 | S83 | PSP | AR DHTR NR3C4 | QQQQQQQQQQQQQQQQQQETsPRQQQQQQGEDGsPQAHRRG |
| P10412 | S187 | PSP | H1-4 H1F4 HIST1H1E | AKKAKsPKKAKAAKPKKAPKsPAKAKAVKPKAAKPKTAKPK |
| P10809 | S70 | Sugiyama | HSPD1 HSP60 | AVAVTMGPKGRtVIIEQsWGsPKVTKDGVtVAKsIDLKDKY |
| P11142 | T37 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P11142 | T38 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P11142 | T45 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPtN |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S552 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | KEKQDKIyFMAGsSRKEAEssPFVERLLKKGyEVIyLTEPV |
| P14866 | S101 | Sugiyama | HNRNPL HNRPL P/OKcl.14 | GAAGGGGGGENyDDPHKtPAsPVVHIRGLIDGVVEADLVEA |
| P15559 | S82 | Sugiyama | NQO1 DIA4 NMOR1 | DPANFQYPAESVLAYKEGHLsPDIVAEQKKLEAADLVIFQF |
| P16152 | S56 | Sugiyama | CBR1 CBR CRN SDR21C1 | TARDVTRGQAAVQQLQAEGLsPRFHQLDIDDLQsIRALRDF |
| P17066 | T40 | Sugiyama | HSPA6 HSP70B' | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P17812 | S575 | Sugiyama | CTPS1 CTPS | LQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD____ |
| P18124 | T17 | Sugiyama | RPL7 | ____MEGVEEKKKEVPAVPEtLKKKRRNFAELKIKRLRKKF |
| P18669 | S31 | Sugiyama | PGAM1 PGAMA CDABP0006 | HGEsAWNLENRFsGWyDADLsPAGHEEAKRGGQALRDAGyE |
| P18754 | S11 | Sugiyama | RCC1 CHC1 | __________MsPKRIAKRRsPPADAIPKsKKVKVsHRsHs |
| P19338 | S563 | Sugiyama | NCL | CNKREIEGRAIRLELQGPRGsPNARSQPSKTLFVKGLsEDt |
| P21333 | S1084 | Sugiyama | FLNA FLN FLN1 | PTKPSKVKAFGPGLQGGsAGsPARFtIDTKGAGTGGLGLTV |
| P22059 | S190 | Sugiyama | OSBP OSBP1 | QRWVTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNT |
| P22059 | S193 | Sugiyama | OSBP OSBP1 | VTALELAKAKAVKMLAEsDEsGDEEsVsQtDKTELQNTLRT |
| P22234 | S27 | Sugiyama | PAICS ADE2 AIRC PAIS | LNIGKKLYEGKtKEVyELLDsPGKVLLQsKDQItAGNAARK |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P22626 | S225 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GNFGFGDsRGGGGNFGPGPGsNFRGGsDGyGsGRGFGDGyN |
| P22626 | S259 | Sugiyama | HNRNPA2B1 HNRPA2B1 | GFGDGyNGyGGGPGGGNFGGsPGyGGGRGGYGGGGPGYGNQ |
| P22681 | S900 | Sugiyama | CBL CBL2 RNF55 | IAQNNIEMAKNILREFVSIssPAHVAT______________ |
| P23246 | T687 | Sugiyama | SFPQ PSF | FGQGGAGPVGGQGPRGMGPGtPAGyGRGREEYEGPNKKPRF |
| P24928 | S1616 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | POLR2A POLR2 | TSPAYEPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNY |
| P24928 | S1619 | EPSD|PSP | POLR2A POLR2 | AYEPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSPT |
| P24928 | S1621 | EPSD|PSP | POLR2A POLR2 | EPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSPTSP |
| P24928 | S1623 | SIGNOR | POLR2A POLR2 | RSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSPTSPSY |
| P24928 | S1644 | SIGNOR | POLR2A POLR2 | PTsPSYSPTSPNYSPTSPSYsPTsPSYsPTsPSYSPTSPSY |
| P24928 | S1651 | SIGNOR | POLR2A POLR2 | PTSPNYSPTSPSYsPTsPSYsPTsPSYSPTSPSYsPTsPSY |
| P24928 | S1665 | SIGNOR | POLR2A POLR2 | PTsPSYsPTsPSYSPTSPSYsPTsPSYsPTsPSYSPTSPSY |
| P24928 | S1672 | SIGNOR | POLR2A POLR2 | PTsPSYSPTSPSYsPTsPSYsPTsPSYSPTSPSYSPTSPSY |
| P24928 | S1693 | SIGNOR | POLR2A POLR2 | PTsPSYSPTSPSYSPTSPSYsPTsPSYSPTSPSYSPTSPSY |
| P24928 | S1714 | SIGNOR | POLR2A POLR2 | PTsPSYSPTSPSYSPTSPSYsPTsPSYsPTsPSYSPTSPSY |
| P24928 | S1721 | SIGNOR | POLR2A POLR2 | PTSPSYSPTSPSYsPTsPSYsPTsPSYSPTSPSYsPTsPSY |
| P24928 | S1735 | SIGNOR | POLR2A POLR2 | PTsPSYsPTsPSYSPTSPSYsPTsPSYSPTSPNYSPTSPNY |
| P24928 | S1763 | SIGNOR | POLR2A POLR2 | PTSPNYSPTSPNYTPTSPSYsPTsPSYSPTSPNYTPTSPNY |
| P24928 | S1784 | SIGNOR | POLR2A POLR2 | PTsPSYSPTSPNYTPTSPNYsPTsPSYSPTSPSYSPTSPSY |
| P24928 | S1861 | SIGNOR | POLR2A POLR2 | PtsPsysPssPEytPtsPKysPtsPKysPtsPKysPtsPty |
| P24928 | S1868 | SIGNOR | POLR2A POLR2 | PssPEytPtsPKysPtsPKysPtsPKysPtsPtysPttPKy |
| P24928 | S1875 | SIGNOR | POLR2A POLR2 | PtsPKysPtsPKysPtsPKysPtsPtysPttPKysPtsPty |
| P24928 | S1878 | SIGNOR | POLR2A POLR2 | PKysPtsPKysPtsPKysPtsPtysPttPKysPtsPtysPt |
| P24928 | S1882 | SIGNOR | POLR2A POLR2 | PtsPKysPtsPKysPtsPtysPttPKysPtsPtysPtsPVy |
| P24928 | S1889 | SIGNOR | POLR2A POLR2 | PtsPKysPtsPtysPttPKysPtsPtysPtsPVytPtsPKy |
| P24928 | S1896 | SIGNOR | POLR2A POLR2 | PtsPtysPttPKysPtsPtysPtsPVytPtsPKysPtsPty |
| P24928 | S1910 | SIGNOR | POLR2A POLR2 | PtsPtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPty |
| P24928 | S1913 | Sugiyama | POLR2A POLR2 | PtysPtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPt |
| P24928 | S1917 | SIGNOR | POLR2A POLR2 | PtsPVytPtsPKysPtsPtysPtsPKysPtsPtysPtsPKG |
| P24928 | S1924 | SIGNOR | POLR2A POLR2 | PtsPKysPtsPtysPtsPKysPtsPtysPtsPKGstYsPts |
| P24928 | S1931 | SIGNOR | POLR2A POLR2 | PtsPtysPtsPKysPtsPtysPtsPKGstYsPtsPGYsPts |
| P24928 | S1941 | SIGNOR | POLR2A POLR2 | PKysPtsPtysPtsPKGstYsPtsPGYsPtsPTYSLTsPAI |
| P24928 | S1948 | SIGNOR | POLR2A POLR2 | PtysPtsPKGstYsPtsPGYsPtsPTYSLTsPAIsPDDsDE |
| P24928 | T1525 | PSP | POLR2A POLR2 | SAPsPMGGIsPAMTPWNQGAtPAYGAWsPSVGSGMtPGAAG |
| P24928 | T1540 | PSP | POLR2A POLR2 | WNQGAtPAYGAWsPSVGSGMtPGAAGFSPSAASDASGFSPG |
| P24928 | T1618 | EPSD|PSP | POLR2A POLR2 | PAYEPRSPGGYTPQSPSysPtsPsYsPTsPSYSPTSPNYSP |
| P24928 | T1919 | Sugiyama | POLR2A POLR2 | sPVytPtsPKysPtsPtysPtsPKysPtsPtysPtsPKGst |
| P25054 | S1042 | Sugiyama | APC DP2.5 | DtPINYSLKysDEQLNsGRQsPsQNERWARPKHIIEDEIKQ |
| P25786 | S14 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | _______MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQGSA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P27797 | S52 | Sugiyama | CALR CRTC | GWtsRWIEsKHKSDFGKFVLssGKFyGDEEKDKGLQTSQDA |
| P27797 | T34 | Sugiyama | CALR CRTC | LAVAEPAVYFKEQFLDGDGWtsRWIEsKHKSDFGKFVLssG |
| P27824 | S362 | Sugiyama | CANX | WDEDMDGEWEAPQIANPRCEsAPGCGVWQRPVIDNPNyKGK |
| P27824 | S583 | Sugiyama | CANX | VsQEEEDRKPKAEEDEILNRsPRNRKPRRE___________ |
| P29401 | S332 | Sugiyama | TKT | GDKIATRKAYGQALAKLGHAsDRIIALDGDtKNstFsEIFK |
| P29692 | S133 | Sugiyama | EEF1D EF1D | NVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKPAtPAEDDE |
| P29692 | S162 | Sugiyama | EEF1D EF1D | AKKPAtPAEDDEDDDIDLFGsDNEEEDKEAAQLREERLRQY |
| P29692 | T125 | Sugiyama | EEF1D EF1D | IsKLEARLNVLEKssPGHRAtAPQtQHVsPMRQVEPPAKKP |
| P29692 | T147 | Sugiyama | EEF1D EF1D | PQtQHVsPMRQVEPPAKKPAtPAEDDEDDDIDLFGsDNEEE |
| P29966 | S26 | Sugiyama | MARCKS MACS PRKCSL | SKTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAs |
| P29966 | S27 | Sugiyama | MARCKS MACS PRKCSL | KTAAKGEAAAERPGEAAVAssPsKANGQENGHVKVNGDAsP |
| P31943 | S104 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | EVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P31943 | T100 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | HRyVEVFKSNNVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P33316 | S88 | Sugiyama | DUT | RGASTVGAAGWKGELPKAGGsPAPGPEtPAIsPsKRARPAE |
| P34931 | T39 | Sugiyama | HSPA1L | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P34931 | T40 | Sugiyama | HSPA1L | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P34931 | T47 | Sugiyama | HSPA1L | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPQN |
| P35251 | S1088 | Sugiyama | RFC1 RFC140 | KEAHLtPYsLQAIKASRHstsPSLDsEyNEELNEDDsQsDE |
| P35269 | T389 | Sugiyama | GTF2F1 RAP74 | PPKRERKPsGGSSRGNsRPGtPsAEGGstsstLRAAASKLE |
| P37231 | S112 | EPSD|PSP | PPARG NR1C3 | DYKYDLKLQEyQSAIKVEPAsPPYYSEKTQLYNKPHEEPSN |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | T180 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | RNFsDNQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL_ |
| P37802 | T190 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | GKNVIGLQMGtNRGAsQAGMtGyGMPRQIL___________ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40818 | S719 | Sugiyama | USP8 KIAA0055 UBPY | KPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtPT |
| P41091 | T109 | Sugiyama | EIF2S3 EIF2G | YKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLVRH |
| P42166 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGtEsRsstPLPtIsssAENtRQNGsNDs |
| P42167 | T160 | Sugiyama | TMPO LAP2 | KLYEKKLLKLREQGTESRsstPLPTISsSAENTRQNGSNDS |
| P42898 | T34 | Sugiyama | MTHFR | CLEGSASSGSESSKDSSRCStPGLDPERHERLREKMRRRLE |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46777 | S176 | Sugiyama | RPL5 MSTP030 | GNKVFGALKGAVDGGLsIPHstKRFPGyDsEsKEFNAEVHR |
| P46783 | S146 | Sugiyama | RPS10 | TYRRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ_ |
| P46783 | T148 | Sugiyama | RPS10 | RRSAVPPGADKKAEAGAGsAtEFQFRGGFGRGRGQPPQ___ |
| P46937 | T119 | Sugiyama | YAP1 YAP65 | PEPKsHsRQAstDAGtAGALtPQHVRAHssPAsLQLGAVsP |
| P48741 | T40 | Sugiyama | HSPA7 HSP70B | VGVFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQ |
| P49023 | S303 | Sugiyama | PXN | QRADGERCWAAGWPRDGGRssPGGQDEGGFMAQGKtGsssP |
| P49736 | S27 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sFtMAssPAQRRRGNDPLtssPGRssRRtDALtssPGRDLP |
| P50750 | S347 | GPS6|EPSD|PSP | CDK9 CDC2L4 TAK | MLSTHLTSMFEyLAPPRRKGsQItQQstNQsRNPAttNQtE |
| P50750 | S353 | GPS6|EPSD|PSP | CDK9 CDC2L4 TAK | TSMFEyLAPPRRKGsQItQQstNQsRNPAttNQtEFERVF_ |
| P50750 | S357 | GPS6|EPSD | CDK9 CDC2L4 TAK | EyLAPPRRKGsQItQQstNQsRNPAttNQtEFERVF_____ |
| P50750 | S7 | Sugiyama | CDK9 CDC2L4 TAK | ______________MAKQYDsVECPFCDEVSKyEKLAKIGQ |
| P50750 | T186 | GPS6|EPSD|PSP | CDK9 CDC2L4 TAK | ADFGLARAFsLAKNSQPNRytNRVVTLWYRPPELLLGERDY |
| P50750 | T29 | Sugiyama | CDK9 CDC2L4 TAK | ECPFCDEVSKyEKLAKIGQGtFGEVFKARHRKTGQKVALKK |
| P50750 | T350 | GPS6|EPSD | CDK9 CDC2L4 TAK | THLTSMFEyLAPPRRKGsQItQQstNQsRNPAttNQtEFER |
| P50750 | T354 | GPS6|EPSD|PSP | CDK9 CDC2L4 TAK | SMFEyLAPPRRKGsQItQQstNQsRNPAttNQtEFERVF__ |
| P50750 | T362 | GPS6|EPSD|PSP|Sugiyama | CDK9 CDC2L4 TAK | PRRKGsQItQQstNQsRNPAttNQtEFERVF__________ |
| P50750 | T363 | GPS6|EPSD|PSP|Sugiyama | CDK9 CDC2L4 TAK | RRKGsQItQQstNQsRNPAttNQtEFERVF___________ |
| P50750 | T366 | Sugiyama | CDK9 CDC2L4 TAK | GsQItQQstNQsRNPAttNQtEFERVF______________ |
| P51858 | S165 | Sugiyama | HDGF HMG1L2 | AKEKNEKGALKRRAGDLLEDsPKRPKEAENPEGEEKEAAtL |
| P51991 | S358 | Sugiyama | HNRNPA3 HNRPA3 | QQQSNYGPMKGGsFGGRssGsPyGGGyGsGGGsGGyGsRRF |
| P52948 | S839 | Sugiyama | NUP98 ADAR2 | AEVtLDGVWPTDKTSRCLIKsPDRLADINyEGRLEAVSRKQ |
| P54646 | S176 | Sugiyama | PRKAA2 AMPK AMPK2 | ADFGLSNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVD |
| P54652 | T38 | Sugiyama | HSPA2 | CVGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKN |
| P54652 | T39 | Sugiyama | HSPA2 | VGVFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQ |
| P54652 | T46 | Sugiyama | HSPA2 | KVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVAMNPTN |
| P55081 | T267 | Sugiyama | MFAP1 | ETKKELEENKRsLAALDALNtDDENDEEEyEAWKVRELKRI |
| P55795 | S104 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | EVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPFGCSK |
| P55795 | T100 | Sugiyama | HNRNPH2 FTP3 HNRPH2 | HRyVEVFKSNsVEMDWVLKHtGPNsPDtANDGFVRLRGLPF |
| P55809 | S509 | Sugiyama | OXCT1 OXCT SCOT | LWEGLTVDDVQKSTGCDFAVsPKLMPMQQIAN_________ |
| P60709 | S300 | Sugiyama | ACTB | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P61254 | T8 | Sugiyama | RPL26 | _____________MKFNPFVtsDRsKNRKRHFNAPsHIRRK |
| P61916 | S40 | Sugiyama | NPC2 HE1 | EPVQFKDCGsVDGVIKEVNVsPCPtQPCQLSKGQSYSVNVT |
| P61978 | S284 | Sugiyama | HNRNPK HNRPK | MPPGRGGRPMPPSRRDyDDMsPRRGPPPPPPGRGGRGGsRA |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62263 | T133 | Sugiyama | RPS14 PRO2640 | QsALRALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL__ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62714 | S212 | Sugiyama | PPP2CB | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P62899 | T119 | Sugiyama | RPL31 | PNKLytLVtyVPVttFKNLQtVNVDEN______________ |
| P62942 | S9 | Sugiyama | FKBP1A FKBP1 FKBP12 | ____________MGVQVEtIsPGDGRtFPKRGQtCVVHytG |
| P62942 | T7 | Sugiyama | FKBP1A FKBP1 FKBP12 | ______________MGVQVEtIsPGDGRtFPKRGQtCVVHy |
| P63261 | S300 | Sugiyama | ACTG1 ACTG | NSIMKCDVDIRKDLyANtVLsGGttMyPGIADRMQKEItAL |
| P67775 | S212 | Sugiyama | PPP2CA | EGPMCDLLWSDPDDRGGWGIsPRGAGYTFGQDISETFNHAN |
| P67809 | S102 | Sugiyama | YBX1 NSEP1 YB1 | EDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKGAEA |
| P67809 | Y99 | Sugiyama | YBX1 NSEP1 YB1 | DtKEDVFVHQtAIKKNNPRKyLRsVGDGEtVEFDVVEGEKG |
| P84022 | S208 | SIGNOR|EPSD|PSP | SMAD3 MADH3 | DGETSDHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCE |
| P84022 | S213 | SIGNOR|EPSD|PSP | SMAD3 MADH3 | DHQMNHSMDAGsPNLsPNPMsPAHNNLDLQPVTYCEPAFWC |
| P84022 | T179 | SIGNOR|EPSD|PSP | SMAD3 MADH3 | SIPENTNFPAGIEPQSNIPEtPPPGYLSEDGETSDHQMNHS |
| P85037 | S420 | Sugiyama | FOXK1 MNF | RGVSCFRtPFGPLssRsAPAsPtHPGLMsPRsGGLQtPECL |
| P85037 | S428 | Sugiyama | FOXK1 MNF | PFGPLssRsAPAsPtHPGLMsPRsGGLQtPECLsREGsPIP |
| Q00613 | S363 | Sugiyama | HSF1 HSTF1 | AsVTALtDARGHTDtEGRPPsPPPtstPEKCLsVACLDKNE |
| Q00987 | S166 | PSP | MDM2 | KPSSSHLVSRPstSSRRRAIsEtEENsDELsGERQRKRHKs |
| Q01082 | S2138 | Sugiyama | SPTBN1 SPTB2 | QWDtsKGEQVsQNGLPAEQGsPRMAETVDTsEMVNGAtEQR |
| Q01082 | S2197 | Sugiyama | SPTBN1 SPTB2 | KTALPAQsAAtLPARtQEtPsAQMEGFLNRKHEWEAHNKKA |
| Q02539 | S183 | EPSD|PSP | H1-1 H1F1 HIST1H1A | RKSSKNPKKPKTVKPKKVAKsPAKAKAVKPKAAKARVTKPK |
| Q02543 | T24 | Sugiyama | RPL18A | SGTLREYKVVGRCLPTPKCHtPPLYRMRIFAPNHVVAKSRF |
| Q06830 | T166 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | DLPVGRsVDEtLRLVQAFQFtDKHGEVCPAGWKPGsDtIKP |
| Q07960 | S51 | Sugiyama | ARHGAP1 CDC42GAP RHOGAP1 | KNWPsDEMPDFPKsDDsKsssPELVtHLKWDDPyyDIARHQ |
| Q08AD1 | S1319 | Sugiyama | CAMSAP2 CAMSAP1L1 KIAA1078 | NEsVHsGKRtPRsEsVEGFLsPsRCGsRNGEKDWENAstts |
| Q12931 | S568 | Sugiyama | TRAP1 HSP75 HSPC5 | ISVETDIVVDHYKEEKFEDRsPAAECLSEKETEELMAWMRN |
| Q13033 | S229 | Sugiyama | STRN3 GS2NA SG2NA | SEPNGsVETKNLEQILNGGEsPKQKGQEIKRSSGDVLETFN |
| Q13098 | S468 | Sugiyama | GPS1 COPS1 CSN1 | RRAKAMMLRAAVLRNQIHVKsPPREGsQGELtPANsQsRMs |
| Q13112 | S410 | Sugiyama | CHAF1B CAF1A CAF1P60 MPHOSPH7 MPP7 | LNMRtPDtAKKTKsQtHRGssPGPRPVEGtPASRtQDPssP |
| Q13131 | S187 | Sugiyama | PRKAA1 AMPK1 | ADFGLsNMMsDGEFLRtsCGsPNyAAPEVISGRLYAGPEVD |
| Q13200 | S16 | Sugiyama | PSMD2 TRAP2 | _____MEEGGRDKAPVQPQQsPAAAPGGtDEKPsGKERRDA |
| Q13242 | S211 | Sugiyama | SRSF9 SFRS9 SRP30C | GYsRsRSGsRGRDsPyQsRGsPHyFsPFRPy__________ |
| Q13242 | S216 | Sugiyama | SRSF9 SFRS9 SRP30C | RSGsRGRDsPyQsRGsPHyFsPFRPy_______________ |
| Q13242 | Y214 | Sugiyama | SRSF9 SFRS9 SRP30C | RsRSGsRGRDsPyQsRGsPHyFsPFRPy_____________ |
| Q13247 | S303 | Sugiyama | SRSF6 SFRS6 SRP55 | ENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKRAT |
| Q13283 | S231 | Sugiyama | G3BP1 G3BP | QEEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsW |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13442 | S63 | Sugiyama | PDAP1 HASPP28 | GGDGAAGDPKKEKKsLDsDEsEDEEDDyQQKRKGVEGLIDI |
| Q13509 | S168 | Sugiyama | TUBB3 TUBB4 | GTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLS |
| Q13509 | S172 | Sugiyama | TUBB3 TUBB4 | ISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNATLSIHQL |
| Q13509 | T166 | Sugiyama | TUBB3 TUBB4 | GMGTLLISKVREEYPDRIMNtFsVVPsPKVSDTVVEPYNAT |
| Q14004 | S383 | Sugiyama | CDK13 CDC2L CDC2L5 CHED KIAA1791 | sRRRSPSYSRHSSYERGGDVsPsPyssSsWRRsRsPysPVL |
| Q14103 | S190 | Sugiyama | HNRNPD AUF1 HNRPD | KRAKAMKTKEPVKKIFVGGLsPDtPEEKIREYFGGFGEVES |
| Q14152 | T1379 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EKDREsLRRTKNEtDEDGWttVRR_________________ |
| Q14157 | S467 | Sugiyama | UBAP2L KIAA0144 NICE4 | AAPPPPssPLPsKstsAPQMsPGssDNQsssPQPAQQKLKQ |
| Q14157 | S470 | Sugiyama | UBAP2L KIAA0144 NICE4 | PPPssPLPsKstsAPQMsPGssDNQsssPQPAQQKLKQQKK |
| Q14160 | S504 | Sugiyama | SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL | MKRSIEGRRsEACPCQPDsGsPLPAEEEKRLsAESGLSEDS |
| Q14258 | S100 | Sugiyama | TRIM25 EFP RNF147 ZNF147 | DLAREPPADVWtPPARAsAPsPNAQVACDHCLKEAAVKTCL |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14697 | S58 | Sugiyama | GANAB G2AN KIAA0088 | FKtCEEssFCKRQRsIRPGLsPyRALLDSLQLGPDSLTVHL |
| Q14974 | S12 | Sugiyama | KPNB1 NTF97 | _________MELITILEKtVsPDRLELEAAQKFLERAAVEN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15293 | T76 | Sugiyama | RCN1 RCN | FQYDHEAFLGKEDsKtFDQLtPDEsKERLGKIVDRIDNDGD |
| Q15596 | S469 | SIGNOR|EPSD|PSP | NCOA2 BHLHE75 SRC2 TIF2 | HVSGMQATtPQGSNYALKMNsPsQSSPGMNPGQPTSMLsPR |
| Q15596 | S487 | SIGNOR|EPSD|PSP | NCOA2 BHLHE75 SRC2 TIF2 | MNsPsQSSPGMNPGQPTSMLsPRHRMsPGVAGsPRIPPSQF |
| Q15596 | S493 | SIGNOR|EPSD|PSP | NCOA2 BHLHE75 SRC2 TIF2 | SSPGMNPGQPTSMLsPRHRMsPGVAGsPRIPPSQFSPAGSL |
| Q15596 | S499 | SIGNOR|EPSD|PSP | NCOA2 BHLHE75 SRC2 TIF2 | PGQPTSMLsPRHRMsPGVAGsPRIPPSQFSPAGSLHSPVGV |
| Q15637 | S82 | Sugiyama | SF1 ZFM1 ZNF162 | TRKLRtGDLGIPPNPEDRsPsPEPIyNsEGKRLNTREFRTR |
| Q15642 | T302 | Sugiyama | TRIP10 CIP4 STOT STP | VEFEDFsQPMNRAPsDssLGtPsDGRPELRGPGRSRTKRWP |
| Q15648 | T1032 | PSP | MED1 ARC205 CRSP1 CRSP200 DRIP205 DRIP230 PBP PPARBP PPARGBP RB18A TRAP220 TRIP2 | RKKADtEGKsPsHssSNRPFtPPtSTGGSKsPGsAGRsQtP |
| Q15773 | S238 | Sugiyama | MLF2 | GAGGRRAEGPPRLAIQGPEDsPsRQsRRYDW__________ |
| Q15797 | S187 | SIGNOR|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | PLNATFPDSFQQPNSHPFPHsPNSSYPNsPGSSSStYPHsP |
| Q15797 | S195 | SIGNOR|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | SFQQPNSHPFPHsPNSSYPNsPGSSSStYPHsPTSSDPGsP |
| Q15797 | S206 | SIGNOR|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | HsPNSSYPNsPGSSSStYPHsPTSSDPGsPFQMPADTPPPA |
| Q15797 | S214 | SIGNOR|EPSD|PSP | SMAD1 BSP1 MADH1 MADR1 | NsPGSSSStYPHsPTSSDPGsPFQMPADTPPPAYLPPEDPM |
| Q16204 | S244 | Sugiyama | CCDC6 D10S170 TST1 | LEAEKRILQEKLDQPVsAPPsPRDIsMEIDsPENMMRHIRF |
| Q16658 | S234 | Sugiyama | FSCN1 FAN1 HSN SNL | LEFRsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELF |
| Q27J81 | S1204 | Sugiyama | INF2 C14orf151 C14orf173 | ALDtsLDKsFsEDAVtDssGsGtLPRARGRASKGTGKRRKK |
| Q27J81 | T1199 | Sugiyama | INF2 C14orf151 C14orf173 | tAPEsALDtsLDKsFsEDAVtDssGsGtLPRARGRASKGTG |
| Q32P51 | S95 | Sugiyama | HNRNPA1L2 HNRNPA1L | TPHKVDGRVVEPKRAVsREDsQRPGAHLtVKKIFVGGIKED |
| Q53EL6 | S94 | Sugiyama | PDCD4 H731 | GDsVsDsGsDALRSGLtVPtsPKGRLLDRRSRSGKGRGLPK |
| Q5JSH3 | S561 | Sugiyama | WDR44 RPH11 | KNAFDYFNNMRMKYNtEGRVsPsPsQEsLsssKsDTDtGVC |
| Q5T200 | S879 | Sugiyama | ZC3H13 KIAA0853 | EKHRLLsQVVRPQEsRsLsPsHLTEDRQGRWKEEDRKPERK |
| Q5T5Y3 | S563 | Sugiyama | CAMSAP1 | VAIVRADVVPQQADPEFPRAsPRALGLtANARsPQGQLDts |
| Q6GYQ0 | S860 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | DEFIAERLRSGNASTMTRRGssPGsLEIPKDLPDILNKQNQ |
| Q6PCE3 | S175 | Sugiyama | PGM2L1 BM32A | PFVPYAVQKLKAVAGVMItAsHNRKEDNGYKVYWETGAQIT |
| Q6PGQ7 | S325 | EPSD|PSP | BORA C13orf34 | GtNsNGITNPCIRSPYIDGCsPIKNWSPMRLQMYsGGTQYR |
| Q6PKG0 | S774 | Sugiyama | LARP1 KIAA0731 LARP | LFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtPQLKDS |
| Q6UN15 | S492 | Sugiyama | FIP1L1 FIP1 RHE | DRDRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAE |
| Q6UN15 | T494 | Sugiyama | FIP1L1 FIP1 RHE | DRDRERERTRERERERDHsPtPsVFNsDEERyRYREYAERG |
| Q6VN20 | S369 | Sugiyama | RANBP10 KIAA1464 | RSLSSRsPKsQDsyPGsPsLsPRHGPsssHMHNTGADsPsC |
| Q7L2J0 | S217 | Sugiyama | MEPCE BCDIN3 | LNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPKDItD |
| Q7L2J0 | S60 | Sugiyama | MEPCE BCDIN3 | SGELRGGTERGPGRCAPsAGsPAAAVGREsPGAAAtsSSGP |
| Q7L2J0 | S69 | Sugiyama | MEPCE BCDIN3 | RGPGRCAPsAGsPAAAVGREsPGAAAtsSSGPQAQQHRGGG |
| Q7L2J0 | T213 | Sugiyama | MEPCE BCDIN3 | DPLNLNSLLDEEVSRtLNAEtPKssPLPAKGRDPVEILIPK |
| Q7Z2W4 | S378 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | NWKsLtsWtNDQGARRKtVFsPtLPAARssLGsLQtPEAVt |
| Q7Z417 | S692 | Sugiyama | NUFIP2 KIAA1321 PIG1 | IWNLQKQDPKRIItyNEAMDsPDQ_________________ |
| Q86VM9 | S609 | Sugiyama | ZC3H18 NHN1 | HSSFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAPPP |
| Q86VM9 | T611 | Sugiyama | ZC3H18 NHN1 | SFSGSRSRsRsFsssPsPsPtPsPHRPsIRTKGEPAPPPGK |
| Q86VV8 | S310 | Sugiyama | RTTN | SYCHEARGTHHSQNPsPGsssPRPSVVGRTGQRPRGDGQDW |
| Q86W92 | S1001 | Sugiyama | PPFIBP1 KIAA1230 | NLTHMLKEDDMFKDFAARsPsAsItDEDsNV__________ |
| Q86W92 | S999 | Sugiyama | PPFIBP1 KIAA1230 | INNLTHMLKEDDMFKDFAARsPsAsItDEDsNV________ |
| Q86WR0 | S187 | Sugiyama | CCDC25 | KKREKEEMKKKREMDELRSYssLMKVENMSSNQDGNDsDEF |
| Q86X29 | S464 | Sugiyama | LSR ILDR3 LISCH | SRPSRGPALtPIRDEEWGGHsPRsPRGWDQEPAREQAGGGW |
| Q8IWW6 | S240 | Sugiyama | ARHGAP12 | SSSsTEQIRAttPPNQGRPDsPVyANLQELKISQSALPPLP |
| Q8IWW6 | T231 | Sugiyama | ARHGAP12 | QDSEsGDELSSSsTEQIRAttPPNQGRPDsPVyANLQELKI |
| Q8IWX8 | S815 | Sugiyama | CHERP DAN26 SCAF6 | RSQSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIP |
| Q8IWX8 | S817 | Sugiyama | CHERP DAN26 SCAF6 | QSRSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDS |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8IZ21 | S118 | Sugiyama | PHACTR4 PRO2963 | PSDAMLKNGHTTPIGNARsssPVQVEEEPVRLAsLRKAIPE |
| Q8N3X1 | T479 | Sugiyama | FNBP4 FBP30 KIAA1014 | FVRAtsPESTSRSSSKtGRDtPENGEtAIGAENsEKIDENs |
| Q8N543 | S256 | PSP | OGFOD1 KIAA1612 TPA1 | WFHGPSLTRPPNYFEPPIPRsPHIPQDHEILYDWINPTYLD |
| Q8N556 | S264 | Sugiyama | AFAP1 AFAP | IKEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssD |
| Q8N556 | S265 | Sugiyama | AFAP1 AFAP | KEAYSGCSGPVDSECPPPPssPVHKAELEKKLssERPssDG |
| Q8N684 | S205 | Sugiyama | CPSF7 | IPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLPYF |
| Q8N684 | T203 | Sugiyama | CPSF7 | GGIPPRAHsRDssDsADGRAtPsENLVPSSARVDKPPSVLP |
| Q8N6T3 | S343 | Sugiyama | ARFGAP1 ARF1GAP | NIDQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDs |
| Q8N6T3 | S345 | Sugiyama | ARFGAP1 ARF1GAP | DQSFWETFGSAEPTKtRKsPssDsWtCADtstERRssDsWE |
| Q8NBJ5 | S612 | Sugiyama | COLGALT1 GLT25D1 PSEC0241 | QKMREQQALSREAKNsDVLQsPLDsAARDEL__________ |
| Q8NBJ7 | T278 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | IDtADGsANHRARVttRMGNtPDsAsDNLGFRCAADAGRPP |
| Q8ND56 | S183 | Sugiyama | LSM14A C19orf13 FAM61A RAP55 RAP55A | GSAFTQDTRsLKtQLsQGRssPQLDPLRKsPtMEQAVQtAs |
| Q8TC07 | S675 | Sugiyama | TBC1D15 | TSAFQSNALPTLSASGARNDsPtQIPVssDVCRLtPA____ |
| Q8TD19 | S29 | Sugiyama | NEK9 KIAA1995 NEK8 NERCC | RHCDsINSDFGSEsGGCGDssPGPSASQGPRAGGGAAEQEE |
| Q8WVV9 | S75 | Sugiyama | HNRNPLL HNRPLL SRRF BLOCK24 | GGGRsFsQPEAGGsHHKVsVsPVVHVRGLCEsVVEADLVEA |
| Q8WXI9 | S122 | Sugiyama | GATAD2B KIAA1150 | DEPVDMSARRsEPERGRLtPsPDIIVLsDNEAssPRsSsRM |
| Q8WXI9 | S135 | Sugiyama | GATAD2B KIAA1150 | ERGRLtPsPDIIVLsDNEAssPRsSsRMEERLKAANLEMFK |
| Q8WY36 | S844 | Sugiyama | BBX HBP2 | KRKARKTKITHLVRtADGRVsPAGGTLDDKPKEQLQRSLPK |
| Q92466 | S26 | Sugiyama | DDB2 | RPETQKTSEIVLRPRNKRsRsPLELEPEAKKLCAKGSGPSR |
| Q92530 | S152 | Sugiyama | PSMF1 | SRIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIP |
| Q92530 | S153 | Sugiyama | PSMF1 | RIVSGIITPIHEQWEKANVssPHREFPPAtAREVDPLRIPP |
| Q96C19 | S74 | Sugiyama | EFHD2 SWS1 | ELSAKLLRRADLNQGIGEPQsPsRRVFNPytEFKEFSRKQI |
| Q96CW6 | S302 | Sugiyama | SLC7A6OS | SRQRMWSKYPLDVQKEFGyDsPHDLDsD_____________ |
| Q96EB6 | S47 | PSP | SIRT1 SIR2L1 | sPAGEPLRKRPRRDGPGLERsPGEPGGAAPEREVPAAARGC |
| Q96EN8 | S530 | Sugiyama | MOCOS | APSADSQADVIPAVMGRRsLsPQEDALTGSRVWNNSSTVNA |
| Q96MH2 | S76 | Sugiyama | HEXIM2 L3 | EDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRRPS |
| Q96MH2 | T74 | Sugiyama | HEXIM2 L3 | EDEDLAGAVGGLGWNsRsPRtQsPGGCsAEAVLARKKHRRR |
| Q96PM5 | S211 | SIGNOR|EPSD|PSP | RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363 | LDMTRYWRQLDDEVAQTPMPsEYQNMtVDILCNDCNGRSTV |
| Q96PM5 | T217 | SIGNOR|EPSD|PSP | RCHY1 ARNIP CHIMP PIRH2 RNF199 ZNF363 | WRQLDDEVAQTPMPsEYQNMtVDILCNDCNGRSTVQFHILG |
| Q96QK1 | S783 | Sugiyama | VPS35 MEM3 TCCCTA00141 | tEQINKHFHNtLEHLRLRREsPEsEGPIyEGLIL_______ |
| Q96T37 | S670 | Sugiyama | RBM15 OTT OTT1 | GRHLDRsPEsDRPRKRHCAPsPDRsPELsssRDRYNsDNDR |
| Q99459 | T385 | Sugiyama | CDC5L KIAA0432 PCDC5RP | EAQNLMALtNVDtPLKGGLNtPLHEsDFsGVtPQRQVVQtP |
| Q99459 | T396 | Sugiyama | CDC5L KIAA0432 PCDC5RP | DtPLKGGLNtPLHEsDFsGVtPQRQVVQtPNtVLstPFRtP |
| Q99569 | S314 | Sugiyama | PKP4 | RQTSNPNGPTPQyQtTARVGsPLTLTDAQTRVAsPSQGQVG |
| Q9BQE3 | S439 | Sugiyama | TUBA1C TUBA6 | SEAREDMAALEKDyEEVGADsADGEDEGEEy__________ |
| Q9BVG9 | S16 | Sugiyama | PTDSS2 PSS2 | _____MRRGERRDAGGPRPEsPVPAGRAsLEEPPDGPSAGQ |
| Q9BWH6 | S80 | Sugiyama | RPAP1 KIAA1403 | DNLPDLPPALVPsPPKRARPsPGHCLPEDEDPEERLRRHDQ |
| Q9BX95 | S112 | Sugiyama | SGPP1 SPP1 | GLAAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLF |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9C0C2 | S1103 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | KRGWVGEFSLSVGPQREAAFsPGQQDWsRDFCIEASERsyQ |
| Q9C0C2 | S435 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | DAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAALPQGQG |
| Q9C0C2 | S672 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | TLARAETtQARtEAQDLCRAsPEPPGPEsSSRWLDDLLAsP |
| Q9H0D6 | T439 | SIGNOR|EPSD|PSP | XRN2 | KEKRKRMKRDQPAFtPsGILtPHALGsRNsPGsQVAsNPRQ |
| Q9H2U2 | S316 | Sugiyama | PPA2 HSPC124 | SDSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK__ |
| Q9H2U2 | S317 | Sugiyama | PPA2 HSPC124 | DSPFRCtQEEARsLVEsVsssPNKEsNEEEQVWHFLGK___ |
| Q9H4A3 | S1261 | Sugiyama | WNK1 HSN2 KDP KIAA0344 PRKWNK1 | GIPTSSLTQVVHSAGRRFIVsPVPEsRLRESKVFPSEITDT |
| Q9H6F5 | S91 | Sugiyama | CCDC86 CYCLON | RLQQGAGLEsPQGQPEPGAAsPQRQQDLHLEsPQRQPEysP |
| Q9H773 | S85 | Sugiyama | DCTPP1 XTP3TPA CDA03 | GELAELFQWKTDGEPGPQGWsPRERAALQEELSDVLIYLVA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9HC35 | S146 | Sugiyama | EML4 C2orf2 EMAPL4 | REKKEEsHsNDQsPQIRAsPsPQPssQPLQIHRQtPEsKNA |
| Q9NQ39 | S157 | Sugiyama | RPS10P5 RPS10L | TYRRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ_ |
| Q9NQ39 | T159 | Sugiyama | RPS10P5 RPS10L | RRCSVPPGADKKAEAGAGsAtEFQFRGRCGRGRGQPPQ___ |
| Q9NQR4 | S207 | Sugiyama | NIT2 CUA002 | HWELLQRSRAVDNQVyVAtAsPARDDKASYVAWGHSTVVNP |
| Q9NR19 | S30 | Sugiyama | ACSS2 ACAS2 | sGsGSRGQEEAGAGGRARsWsPPPEVsRSAHVPSLQRYREL |
| Q9NTJ3 | T44 | Sugiyama | SMC4 CAPC SMC4L1 | DGAssDAEPEPPsGRtEsPAtAAEtAsEELDNRSLEEILNS |
| Q9NUQ3 | S97 | Sugiyama | TXLNG CXorf15 ELRG LSR5 | KHSLEEDEGsDFItENRNLVsPAyCtQEsREEIPGGEARTD |
| Q9NZL9 | S16 | Sugiyama | MAT2B TGR MSTP045 Nbla02999 UNQ2435/PRO4995 | _____MVGREKELsIHFVPGsCRLVEEEVNIPNRRVLVtGA |
| Q9UGV2 | S361 | Sugiyama | NDRG3 | sPFsRsVtsNQsDGtQESCEsPDVLDRHQTMEVsC______ |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UHI6 | T705 | Sugiyama | DDX20 DP103 GEMIN3 | sEstPVDDRIsLEQPPNGsDtPNPEKyQEsPGIQMKTRLKE |
| Q9UI15 | T190 | Sugiyama | TAGLN3 NP25 | GQNVIGLQMGSNKGAsQAGMtGyGMPRQIM___________ |
| Q9UII2 | S39 | Sugiyama | ATP5IF1 ATPI ATPIF1 | TMQARGFGsDQSENVDRGAGsIREAGGAFGKREQAEEERyF |
| Q9UJU6 | S232 | Sugiyama | DBNL CMAP SH3P7 PP5423 | RELREAARREQRyQEQGGEAsPQRtWEQQQEVVSRNRNEQE |
| Q9UKI8 | S159 | Sugiyama | TLK1 KIAA0137 | IGGRGHKIsDyFEYQGGNGssPVRGIPPAIRsPQNsHsHst |
| Q9UKS6 | S319 | Sugiyama | PACSIN3 | FEEWsLDtQRtIsRKEKGGRsPDEVtLtsIVPTRDGTAPPP |
| Q9UKS6 | T324 | Sugiyama | PACSIN3 | LDtQRtIsRKEKGGRsPDEVtLtsIVPTRDGTAPPPQsPGs |
| Q9UNE7 | S19 | Sugiyama | STUB1 CHIP PP1131 | __MKGKEEKEGGARLGAGGGsPEKsPsAQELKEQGNRLFVG |
| Q9UNE7 | S23 | Sugiyama | STUB1 CHIP PP1131 | GKEEKEGGARLGAGGGsPEKsPsAQELKEQGNRLFVGRKYP |
| Q9UNX3 | T8 | Sugiyama | RPL26L1 RPL26P1 | _____________MKFNPFVtsDRsKNRKRHFNAPSHVRRK |
| Q9UNZ2 | S271 | Sugiyama | NSFL1C UBXN2C | KAFTGEGQKLGstAPQVLstssPAQQAENEAKAsSSILIDE |
| Q9UPQ0 | S217 | Sugiyama | LIMCH1 KIAA1102 | GRDDsFDsLDsFGsRsRQtPsPDVVLRGssDGRGsDsEsDL |
| Q9UPW0 | S223 | Sugiyama | FOXJ3 KIAA1041 | AINTVTNKVTLYNTDQDGsDsPRSSLNNSLSDQSLASVNLN |
| Q9UQ35 | S1103 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sPsLQSKSQTsPKGGRsRsssPVtELAsRsPIRQDRGEFsA |
| Q9UQ35 | S2132 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | SRMsCFsRPsMsPtPLDRCRsPGMLEPLGssRtPMsVLQQA |
| Q9UQ35 | T1655 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | RSRSGSSSKGRGPsPEGssstEssPEHPPKSRTARRGsRSs |
| Q9UQ35 | T328 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | APFsEPGttstQRPssPEtAtKQPssPYEDKDKDKKEKsAt |
| Q9UQ35 | T866 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sGtPPRQGsItsPQANEQsVtPQRRsCFEssPDPELKsRtP |
| Q9Y2B0 | S63 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | AQVDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
| Q9Y2V2 | S41 | Sugiyama | CARHSP1 | LDtPRsRERsPsPLRGNVVPsPLPtRRtRtFsAtVRASQGP |
| Q9Y4P8 | T415 | Sugiyama | WIPI2 CGI-50 | LVTQTYGAAAGKGTYVPssPtRLAYTDDLGAVGGACLEDEA |
| Q9Y6G9 | S207 | Sugiyama | DYNC1LI1 DNCLI1 | EQKLIRDFQEyVEPGEDFPAsPQRRNtAsQEDKDDsVVLPL |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 0.000001 | 5.960 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 0.000002 | 5.785 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 0.000002 | 5.606 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 0.000008 | 5.084 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 0.000018 | 4.739 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 0.000026 | 4.582 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 0.000031 | 4.508 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 0.000046 | 4.337 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 0.000050 | 4.297 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 0.000054 | 4.264 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 0.000111 | 3.954 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 0.000196 | 3.707 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 0.000203 | 3.693 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 0.000196 | 3.707 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 0.000197 | 3.705 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 0.000222 | 3.653 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 0.000248 | 3.606 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 0.000299 | 3.524 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 0.000287 | 3.542 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 0.000325 | 3.489 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 0.000325 | 3.489 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 0.000354 | 3.451 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 0.000368 | 3.434 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 0.000400 | 3.398 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 0.000421 | 3.376 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 0.000541 | 3.267 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 0.000541 | 3.267 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 0.000636 | 3.197 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 0.000689 | 3.162 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 0.000743 | 3.129 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 0.000737 | 3.133 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 0.000797 | 3.098 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 0.000799 | 3.098 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 0.000915 | 3.039 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 0.001092 | 2.962 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 0.001134 | 2.945 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 0.001128 | 2.948 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 0.001135 | 2.945 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 0.001134 | 2.945 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 0.001128 | 2.948 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 0.001284 | 2.892 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 0.001381 | 2.860 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 0.001381 | 2.860 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 0.001577 | 2.802 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 0.001577 | 2.802 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 0.001566 | 2.805 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 0.001956 | 2.709 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 0.002076 | 2.683 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 0.002221 | 2.653 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 0.002221 | 2.653 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 0.002169 | 2.664 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 0.002150 | 2.668 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 0.002478 | 2.606 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 0.002478 | 2.606 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 0.002384 | 2.623 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 0.002476 | 2.606 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 0.002550 | 2.593 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 0.002731 | 2.564 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 0.002866 | 2.543 | 1 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 0.003296 | 2.482 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 0.003429 | 2.465 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 0.003659 | 2.437 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 0.003879 | 2.411 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 0.003965 | 2.402 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 0.004233 | 2.373 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 0.004261 | 2.371 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 0.004464 | 2.350 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 0.004523 | 2.345 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 0.004906 | 2.309 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 0.004891 | 2.311 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 0.005281 | 2.277 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 0.005686 | 2.245 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 0.005686 | 2.245 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 0.005654 | 2.248 | 1 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 0.005956 | 2.225 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 0.006222 | 2.206 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 0.006222 | 2.206 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 0.006485 | 2.188 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 0.006631 | 2.178 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 0.006786 | 2.168 | 1 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 0.007292 | 2.137 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 0.007475 | 2.126 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 0.007858 | 2.105 | 1 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 0.008219 | 2.085 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 0.008356 | 2.078 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 0.009120 | 2.040 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 0.009120 | 2.040 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 0.009001 | 2.046 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 0.009257 | 2.034 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 0.009551 | 2.020 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 0.010171 | 1.993 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 0.009970 | 2.001 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 0.009970 | 2.001 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 0.011511 | 1.939 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 0.011945 | 1.923 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 0.012295 | 1.910 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 0.012451 | 1.905 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 0.013284 | 1.877 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 0.013284 | 1.877 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 0.014395 | 1.842 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 0.013685 | 1.864 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 0.013762 | 1.861 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 0.014175 | 1.848 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 0.014127 | 1.850 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 0.014006 | 1.854 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 0.014805 | 1.830 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 0.016550 | 1.781 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 0.017034 | 1.769 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 0.017091 | 1.767 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 0.017427 | 1.759 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 0.016550 | 1.781 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 0.017427 | 1.759 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 0.018992 | 1.721 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 0.018992 | 1.721 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 0.018992 | 1.721 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 0.018992 | 1.721 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 0.018992 | 1.721 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 0.018992 | 1.721 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 0.018748 | 1.727 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 0.017807 | 1.749 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 0.018225 | 1.739 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 0.019684 | 1.706 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 0.019999 | 1.699 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 0.020188 | 1.695 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 0.020563 | 1.687 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 0.021495 | 1.668 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 0.021389 | 1.670 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 0.022347 | 1.651 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 0.020655 | 1.685 | 1 | 1 |
| Mitotic Prophase | R-HSA-68875 | 0.021274 | 1.672 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 0.021029 | 1.677 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 0.022177 | 1.654 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 0.026517 | 1.576 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 0.026517 | 1.576 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 0.026517 | 1.576 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 0.026517 | 1.576 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 0.026517 | 1.576 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 0.026517 | 1.576 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 0.027351 | 1.563 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 0.027444 | 1.562 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 0.027260 | 1.564 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 0.027260 | 1.564 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 0.027260 | 1.564 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 0.027260 | 1.564 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 0.027260 | 1.564 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 0.027604 | 1.559 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 0.027444 | 1.562 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 0.027444 | 1.562 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 0.023571 | 1.628 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 0.026839 | 1.571 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 0.027444 | 1.562 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 0.025671 | 1.591 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 0.024082 | 1.618 | 0 | 0 |
| Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells | R-HSA-210746 | 0.027636 | 1.559 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 0.027636 | 1.559 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 0.029926 | 1.524 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 0.030372 | 1.518 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 0.030467 | 1.516 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 0.030983 | 1.509 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 0.031731 | 1.499 | 1 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 0.031749 | 1.498 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 0.031820 | 1.497 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 0.032660 | 1.486 | 1 | 1 |
| Signaling by ALK | R-HSA-201556 | 0.033037 | 1.481 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 0.038284 | 1.417 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 0.038284 | 1.417 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 0.038284 | 1.417 | 0 | 0 |
| M Phase | R-HSA-68886 | 0.034481 | 1.462 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 0.037578 | 1.425 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 0.040192 | 1.396 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 0.040192 | 1.396 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 0.040192 | 1.396 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 0.040192 | 1.396 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 0.040530 | 1.392 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 0.040530 | 1.392 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 0.040530 | 1.392 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 0.041740 | 1.379 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 0.042084 | 1.376 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 0.042084 | 1.376 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 0.042084 | 1.376 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 0.043992 | 1.357 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 0.047462 | 1.324 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 0.047462 | 1.324 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 0.044510 | 1.352 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 0.049922 | 1.302 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 0.046452 | 1.333 | 0 | 0 |
| S Phase | R-HSA-69242 | 0.049474 | 1.306 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 0.046452 | 1.333 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 0.047700 | 1.321 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 0.050970 | 1.293 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 0.050970 | 1.293 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 0.050970 | 1.293 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 0.050970 | 1.293 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 0.051194 | 1.291 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 0.051223 | 1.291 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 0.052664 | 1.278 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 0.053212 | 1.274 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 0.053576 | 1.271 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 0.053576 | 1.271 | 0 | 0 |
| ARL13B-mediated ciliary trafficking of INPP5E | R-HSA-5624958 | 0.055016 | 1.260 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 0.055016 | 1.260 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 0.056058 | 1.251 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 0.058843 | 1.230 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 0.058843 | 1.230 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 0.058843 | 1.230 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 0.058843 | 1.230 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 0.065271 | 1.185 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 0.060761 | 1.216 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 0.063629 | 1.196 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 0.058885 | 1.230 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 0.060175 | 1.221 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 0.063629 | 1.196 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 0.058843 | 1.230 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 0.065678 | 1.183 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 0.066864 | 1.175 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 0.067104 | 1.173 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 0.068033 | 1.167 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 0.069117 | 1.160 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 0.069286 | 1.159 | 1 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 0.070858 | 1.150 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 0.071123 | 1.148 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 0.073653 | 1.133 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 0.076504 | 1.116 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 0.076618 | 1.116 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 0.076618 | 1.116 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 0.090270 | 1.044 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 0.090270 | 1.044 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 0.090270 | 1.044 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 0.080359 | 1.095 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 0.080359 | 1.095 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 0.080359 | 1.095 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 0.080359 | 1.095 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 0.080359 | 1.095 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 0.082346 | 1.084 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 0.078046 | 1.108 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 0.086283 | 1.064 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 0.079104 | 1.102 | 1 | 1 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 0.086637 | 1.062 | 1 | 1 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 0.086954 | 1.061 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 0.089906 | 1.046 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 0.086283 | 1.064 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 0.078151 | 1.107 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 0.082346 | 1.084 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 0.086563 | 1.063 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 0.090270 | 1.044 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 0.080126 | 1.096 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 0.083836 | 1.077 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 0.082346 | 1.084 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 0.077822 | 1.109 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 0.087395 | 1.059 | 1 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 0.090757 | 1.042 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 0.092805 | 1.032 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 0.095297 | 1.021 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 0.095634 | 1.019 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 0.098072 | 1.008 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 0.099172 | 1.004 | 0 | 0 |
| Drug resistance of KIT mutants | R-HSA-9669937 | 0.117568 | 0.930 | 0 | 0 |
| KIT mutants bind TKIs | R-HSA-9669921 | 0.117568 | 0.930 | 0 | 0 |
| Nilotinib-resistant KIT mutants | R-HSA-9669926 | 0.117568 | 0.930 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 0.117568 | 0.930 | 0 | 0 |
| Deletions in the AXIN1 gene destabilize the destruction complex | R-HSA-5467345 | 0.117568 | 0.930 | 0 | 0 |
| Imatinib-resistant KIT mutants | R-HSA-9669917 | 0.117568 | 0.930 | 0 | 0 |
| Sunitinib-resistant KIT mutants | R-HSA-9669934 | 0.117568 | 0.930 | 0 | 0 |
| Masitinib-resistant KIT mutants | R-HSA-9669924 | 0.117568 | 0.930 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 0.117568 | 0.930 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 0.117568 | 0.930 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 0.117568 | 0.930 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 0.117568 | 0.930 | 0 | 0 |
| Dasatinib-resistant KIT mutants | R-HSA-9669914 | 0.117568 | 0.930 | 0 | 0 |
| Regorafenib-resistant KIT mutants | R-HSA-9669929 | 0.117568 | 0.930 | 0 | 0 |
| Sorafenib-resistant KIT mutants | R-HSA-9669936 | 0.117568 | 0.930 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 0.104748 | 0.980 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 0.104748 | 0.980 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 0.104748 | 0.980 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 0.100878 | 0.996 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 0.100878 | 0.996 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 0.100878 | 0.996 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 0.100878 | 0.996 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 0.111234 | 0.954 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 0.120661 | 0.918 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 0.104244 | 0.982 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 0.105614 | 0.976 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 0.103639 | 0.984 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 0.102147 | 0.991 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 0.102147 | 0.991 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 0.111745 | 0.952 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 0.108596 | 0.964 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 0.110700 | 0.956 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 0.108638 | 0.964 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 0.108884 | 0.963 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 0.108884 | 0.963 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 0.112981 | 0.947 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 0.115856 | 0.936 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 0.120661 | 0.918 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 0.121143 | 0.917 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 0.121143 | 0.917 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 0.122581 | 0.912 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 0.124081 | 0.906 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 0.124143 | 0.906 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 0.124143 | 0.906 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 0.124143 | 0.906 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 0.221320 | 0.655 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 0.221320 | 0.655 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 0.221320 | 0.655 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 0.130298 | 0.885 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 0.130298 | 0.885 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 0.173491 | 0.761 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 0.173491 | 0.761 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 0.173491 | 0.761 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 0.173491 | 0.761 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 0.173491 | 0.761 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 0.173491 | 0.761 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 0.312879 | 0.505 | 0 | 0 |
| t(4;14) translocations of FGFR3 | R-HSA-2033515 | 0.312879 | 0.505 | 0 | 0 |
| Signaling by extracellular domain mutants of KIT | R-HSA-9680187 | 0.312879 | 0.505 | 0 | 0 |
| Signaling by FGFR3 fusions in cancer | R-HSA-8853334 | 0.312879 | 0.505 | 0 | 0 |
| Signaling by juxtamembrane domain KIT mutants | R-HSA-9669935 | 0.312879 | 0.505 | 0 | 0 |
| SMAD4 MH2 Domain Mutants in Cancer | R-HSA-3311021 | 0.312879 | 0.505 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5660686 | 0.312879 | 0.505 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 0.312879 | 0.505 | 0 | 0 |
| Loss of Function of SMAD4 in Cancer | R-HSA-3304347 | 0.312879 | 0.505 | 0 | 0 |
| Variant SLC6A20 contributes towards hyperglycinuria (HG) and iminoglycinuria (IG) | R-HSA-5619101 | 0.312879 | 0.505 | 0 | 0 |
| SMAD2/3 MH2 Domain Mutants in Cancer | R-HSA-3315487 | 0.312879 | 0.505 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 0.312879 | 0.505 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 0.312879 | 0.505 | 0 | 0 |
| Defective VWF binding to collagen type I | R-HSA-9845622 | 0.312879 | 0.505 | 0 | 0 |
| Signaling by kinase domain mutants of KIT | R-HSA-9669933 | 0.312879 | 0.505 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 0.312879 | 0.505 | 0 | 0 |
| Defective ALG1 causes CDG-1k | R-HSA-4549380 | 0.312879 | 0.505 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 0.312879 | 0.505 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 0.131637 | 0.881 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 0.131637 | 0.881 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 0.131637 | 0.881 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 0.131637 | 0.881 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 0.131637 | 0.881 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 0.218552 | 0.660 | 0 | 0 |
| IRS activation | R-HSA-74713 | 0.218552 | 0.660 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 0.218552 | 0.660 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 0.160626 | 0.794 | 0 | 0 |
| RSK activation | R-HSA-444257 | 0.160626 | 0.794 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 0.160626 | 0.794 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 0.142989 | 0.845 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 0.142989 | 0.845 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 0.142989 | 0.845 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 0.142989 | 0.845 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 0.142989 | 0.845 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 0.142989 | 0.845 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 0.142989 | 0.845 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 0.142989 | 0.845 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 0.142989 | 0.845 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 0.142989 | 0.845 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 0.142989 | 0.845 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 0.142989 | 0.845 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 0.191317 | 0.718 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 0.191317 | 0.718 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 0.191317 | 0.718 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 0.264447 | 0.578 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 0.264447 | 0.578 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 0.393676 | 0.405 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 0.393676 | 0.405 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 0.393676 | 0.405 | 0 | 0 |
| Glycogen storage disease type IV (GBE1) | R-HSA-3878781 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 0.393676 | 0.405 | 0 | 0 |
| Defective F8 sulfation at Y1699 | R-HSA-9674519 | 0.393676 | 0.405 | 0 | 0 |
| Defective VWF cleavage by ADAMTS13 variant | R-HSA-9845621 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 0.393676 | 0.405 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 0.393676 | 0.405 | 0 | 0 |
| Enhanced cleavage of VWF variant by ADAMTS13 | R-HSA-9845619 | 0.393676 | 0.405 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 0.393676 | 0.405 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 0.393676 | 0.405 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 0.126217 | 0.899 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 0.126217 | 0.899 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 0.223319 | 0.651 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 0.126383 | 0.898 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 0.190735 | 0.720 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 0.310356 | 0.508 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 0.164317 | 0.784 | 0 | 0 |
| PKA activation | R-HSA-163615 | 0.164317 | 0.784 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 0.164317 | 0.784 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 0.256262 | 0.591 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 0.216267 | 0.665 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 0.184893 | 0.733 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 0.138374 | 0.859 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 0.138374 | 0.859 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 0.242656 | 0.615 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 0.242656 | 0.615 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 0.289802 | 0.538 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 0.289802 | 0.538 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 0.355642 | 0.449 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 0.355642 | 0.449 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 0.355642 | 0.449 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 0.355642 | 0.449 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 0.355642 | 0.449 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 0.355642 | 0.449 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 0.355642 | 0.449 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 0.464977 | 0.333 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 0.464977 | 0.333 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 0.464977 | 0.333 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 0.464977 | 0.333 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 0.464977 | 0.333 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 0.464977 | 0.333 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 0.464977 | 0.333 | 0 | 0 |
| Defective DPM3 causes DPM3-CDG | R-HSA-4719360 | 0.464977 | 0.333 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 0.464977 | 0.333 | 0 | 0 |
| Defective DPM1 causes DPM1-CDG | R-HSA-4717374 | 0.464977 | 0.333 | 0 | 0 |
| Defective DPM2 causes DPM2-CDG | R-HSA-4719377 | 0.464977 | 0.333 | 0 | 0 |
| Defective GSS causes GSS deficiency | R-HSA-5579006 | 0.464977 | 0.333 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 0.464977 | 0.333 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 0.228565 | 0.641 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 0.140146 | 0.853 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 0.269715 | 0.569 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 0.269715 | 0.569 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 0.269715 | 0.569 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 0.269715 | 0.569 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 0.269715 | 0.569 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 0.215064 | 0.667 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 0.323626 | 0.490 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 0.323626 | 0.490 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 0.145083 | 0.838 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 0.251435 | 0.600 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 0.202413 | 0.694 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 0.234926 | 0.629 | 1 | 1 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 0.234926 | 0.629 | 1 | 1 |
| Specification of primordial germ cells | R-HSA-9827857 | 0.297263 | 0.527 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 0.297263 | 0.527 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 0.399818 | 0.398 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 0.399818 | 0.398 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 0.399818 | 0.398 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 0.255322 | 0.593 | 1 | 1 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 0.255322 | 0.593 | 1 | 1 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 0.357453 | 0.447 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 0.357453 | 0.447 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 0.357453 | 0.447 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 0.238044 | 0.623 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 0.325127 | 0.488 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 0.325127 | 0.488 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 0.298673 | 0.525 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 0.239218 | 0.621 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 0.239218 | 0.621 | 1 | 1 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 0.185061 | 0.733 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 0.185061 | 0.733 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 0.239154 | 0.621 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 0.239154 | 0.621 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 0.239154 | 0.621 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 0.353144 | 0.452 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 0.353144 | 0.452 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 0.391034 | 0.408 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 0.391034 | 0.408 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 0.391034 | 0.408 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 0.442518 | 0.354 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 0.527897 | 0.277 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 0.527897 | 0.277 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 0.527897 | 0.277 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 0.527897 | 0.277 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 0.527897 | 0.277 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 0.527897 | 0.277 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 0.527897 | 0.277 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 0.164631 | 0.783 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 0.273695 | 0.563 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 0.273695 | 0.563 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 0.273695 | 0.563 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 0.131208 | 0.882 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 0.196103 | 0.708 | 1 | 1 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 0.236813 | 0.626 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 0.253112 | 0.597 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 0.271192 | 0.567 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 0.381162 | 0.419 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 0.314340 | 0.503 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 0.268261 | 0.571 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 0.169162 | 0.772 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 0.248199 | 0.605 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 0.340678 | 0.468 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 0.424153 | 0.372 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 0.424153 | 0.372 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 0.424153 | 0.372 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 0.424153 | 0.372 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 0.424153 | 0.372 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 0.424153 | 0.372 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 0.424153 | 0.372 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 0.189292 | 0.723 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 0.309431 | 0.509 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 0.283684 | 0.547 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 0.371600 | 0.430 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 0.371600 | 0.430 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 0.279586 | 0.553 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 0.409040 | 0.388 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 0.483478 | 0.316 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 0.483478 | 0.316 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 0.483478 | 0.316 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 0.483478 | 0.316 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 0.396043 | 0.402 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 0.396043 | 0.402 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 0.346057 | 0.461 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 0.309308 | 0.510 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 0.384530 | 0.415 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 0.456625 | 0.340 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 0.298034 | 0.526 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 0.436652 | 0.360 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 0.436652 | 0.360 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 0.436652 | 0.360 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 0.355756 | 0.449 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 0.355756 | 0.449 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 0.414347 | 0.383 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 0.414347 | 0.383 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 0.444566 | 0.352 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 0.444566 | 0.352 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 0.444566 | 0.352 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 0.488296 | 0.311 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 0.488296 | 0.311 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 0.522518 | 0.282 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 0.522518 | 0.282 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 0.522518 | 0.282 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 0.522518 | 0.282 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 0.583421 | 0.234 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 0.583421 | 0.234 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 0.583421 | 0.234 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 0.583421 | 0.234 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 0.583421 | 0.234 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 0.583421 | 0.234 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 0.583421 | 0.234 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 0.408078 | 0.389 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 0.468480 | 0.329 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 0.490633 | 0.309 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 0.490633 | 0.309 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 0.346122 | 0.461 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 0.410460 | 0.387 | 1 | 1 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 0.519039 | 0.285 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 0.492064 | 0.308 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 0.449001 | 0.348 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 0.493057 | 0.307 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 0.559523 | 0.252 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 0.464611 | 0.333 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 0.481132 | 0.318 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 0.511360 | 0.291 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 0.577353 | 0.239 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 0.594431 | 0.226 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 0.558658 | 0.253 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 0.581894 | 0.235 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 0.591216 | 0.228 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 0.604787 | 0.218 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 0.604787 | 0.218 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 0.604787 | 0.218 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 0.604787 | 0.218 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 0.627224 | 0.203 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 0.627224 | 0.203 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 0.627224 | 0.203 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 0.627224 | 0.203 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 0.623456 | 0.205 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 0.397334 | 0.401 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 0.163520 | 0.786 | 1 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 0.424804 | 0.372 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 0.485151 | 0.314 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 0.485151 | 0.314 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 0.220163 | 0.657 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 0.325477 | 0.487 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 0.129520 | 0.888 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 0.239218 | 0.621 | 1 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 0.374126 | 0.427 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 0.374126 | 0.427 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 0.485151 | 0.314 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 0.193908 | 0.712 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 0.577353 | 0.239 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 0.594944 | 0.226 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 0.297404 | 0.527 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 0.428386 | 0.368 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 0.190957 | 0.719 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 0.166377 | 0.779 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 0.182577 | 0.739 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 0.176340 | 0.754 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 0.370522 | 0.431 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 0.144726 | 0.839 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 0.323626 | 0.490 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 0.184680 | 0.734 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 0.381162 | 0.419 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 0.140808 | 0.851 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 0.131051 | 0.883 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 0.555099 | 0.256 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 0.142989 | 0.845 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 0.305686 | 0.515 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 0.574991 | 0.240 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 0.166246 | 0.779 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 0.145805 | 0.836 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 0.239218 | 0.621 | 1 | 1 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 0.428386 | 0.368 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 0.445629 | 0.351 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 0.169057 | 0.772 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 0.391034 | 0.408 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 0.196774 | 0.706 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 0.381162 | 0.419 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 0.463884 | 0.334 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 0.166246 | 0.779 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 0.294343 | 0.531 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 0.291944 | 0.535 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 0.289802 | 0.538 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 0.357453 | 0.447 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 0.130839 | 0.883 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 0.483478 | 0.316 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 0.315231 | 0.501 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 0.488296 | 0.311 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 0.471726 | 0.326 | 1 | 1 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 0.537987 | 0.269 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 0.142989 | 0.845 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 0.548751 | 0.261 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 0.436652 | 0.360 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 0.133579 | 0.874 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 0.268231 | 0.571 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 0.237233 | 0.625 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 0.184163 | 0.735 | 1 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 0.269715 | 0.569 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 0.222565 | 0.653 | 1 | 1 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 0.391034 | 0.408 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 0.483478 | 0.316 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 0.483478 | 0.316 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 0.483478 | 0.316 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 0.559523 | 0.252 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 0.480151 | 0.319 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 0.134333 | 0.872 | 1 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 0.234964 | 0.629 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 0.146753 | 0.833 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 0.146753 | 0.833 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 0.510930 | 0.292 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 0.239154 | 0.621 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 0.581894 | 0.235 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 0.626219 | 0.203 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 0.216267 | 0.665 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 0.391775 | 0.407 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 0.306408 | 0.514 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 0.589145 | 0.230 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 0.249902 | 0.602 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 0.283684 | 0.547 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 0.191317 | 0.718 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 0.166246 | 0.779 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 0.166246 | 0.779 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 0.142473 | 0.846 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 0.289802 | 0.538 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 0.251435 | 0.600 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 0.274843 | 0.561 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 0.325127 | 0.488 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 0.154337 | 0.812 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 0.527897 | 0.277 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 0.184680 | 0.734 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 0.250796 | 0.601 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 0.534787 | 0.272 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 0.541174 | 0.267 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 0.577353 | 0.239 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 0.594431 | 0.226 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 0.591216 | 0.228 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 0.274843 | 0.561 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 0.371600 | 0.430 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 0.542342 | 0.266 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 0.331294 | 0.480 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 0.480151 | 0.319 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 0.218771 | 0.660 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 0.144726 | 0.839 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 0.144726 | 0.839 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 0.519039 | 0.285 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 0.559523 | 0.252 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 0.548751 | 0.261 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 0.594431 | 0.226 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 0.581894 | 0.235 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 0.602985 | 0.220 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 0.593694 | 0.226 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 0.239154 | 0.621 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 0.309431 | 0.509 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 0.414347 | 0.383 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 0.468480 | 0.329 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 0.228565 | 0.641 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 0.436652 | 0.360 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 0.492064 | 0.308 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 0.560216 | 0.252 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 0.242656 | 0.615 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 0.476113 | 0.322 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 0.177253 | 0.751 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 0.177253 | 0.751 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 0.581894 | 0.235 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 0.218552 | 0.660 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 0.218552 | 0.660 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 0.191317 | 0.718 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 0.190735 | 0.720 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 0.289802 | 0.538 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 0.399818 | 0.398 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 0.442518 | 0.354 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 0.527897 | 0.277 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 0.381162 | 0.419 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 0.371600 | 0.430 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 0.299351 | 0.524 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 0.583421 | 0.234 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 0.515253 | 0.288 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 0.537987 | 0.269 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 0.627224 | 0.203 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 0.553775 | 0.257 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 0.383080 | 0.417 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 0.228565 | 0.641 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 0.228565 | 0.641 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 0.386321 | 0.413 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 0.164317 | 0.784 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 0.327656 | 0.485 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 0.327656 | 0.485 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 0.173791 | 0.760 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 0.377910 | 0.423 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 0.518501 | 0.285 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 0.522518 | 0.282 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 0.354069 | 0.451 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 0.263802 | 0.579 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 0.166246 | 0.779 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 0.424153 | 0.372 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 0.542342 | 0.266 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 0.432222 | 0.364 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 0.223319 | 0.651 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 0.335704 | 0.474 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 0.371600 | 0.430 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 0.202386 | 0.694 | 1 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 0.547942 | 0.261 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 0.173491 | 0.761 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 0.173491 | 0.761 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 0.264447 | 0.578 | 0 | 0 |
| Inhibition of nitric oxide production | R-HSA-9636249 | 0.464977 | 0.333 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 0.464977 | 0.333 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 0.274843 | 0.561 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 0.332428 | 0.478 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 0.551132 | 0.259 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 0.269922 | 0.569 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 0.366631 | 0.436 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 0.289686 | 0.538 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 0.443601 | 0.353 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 0.602985 | 0.220 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 0.279827 | 0.553 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 0.218552 | 0.660 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 0.228565 | 0.641 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 0.215064 | 0.667 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 0.399818 | 0.398 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 0.420394 | 0.376 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 0.450151 | 0.347 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 0.434814 | 0.362 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 0.516811 | 0.287 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 0.256277 | 0.591 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 0.442518 | 0.354 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 0.532312 | 0.274 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 0.143618 | 0.843 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 0.516811 | 0.287 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 0.577353 | 0.239 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 0.152801 | 0.816 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 0.594431 | 0.226 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 0.459703 | 0.338 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 0.394259 | 0.404 | 1 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 0.289694 | 0.538 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 0.280081 | 0.553 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 0.362569 | 0.441 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 0.312879 | 0.505 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 0.393676 | 0.405 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 0.393676 | 0.405 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 0.393676 | 0.405 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 0.310356 | 0.508 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 0.164317 | 0.784 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 0.216267 | 0.665 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 0.242656 | 0.615 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 0.464977 | 0.333 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 0.169548 | 0.771 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 0.357453 | 0.447 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 0.325127 | 0.488 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 0.325127 | 0.488 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 0.442518 | 0.354 | 0 | 0 |
| Alanine metabolism | R-HSA-8964540 | 0.527897 | 0.277 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 0.527897 | 0.277 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 0.236813 | 0.626 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 0.304400 | 0.517 | 0 | 0 |
| Kinesins | R-HSA-983189 | 0.347507 | 0.459 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 0.522518 | 0.282 | 0 | 0 |
| Suppression of autophagy | R-HSA-9636569 | 0.583421 | 0.234 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 0.583421 | 0.234 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 0.559523 | 0.252 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 0.494857 | 0.306 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 0.307265 | 0.512 | 1 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 0.217402 | 0.663 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 0.251435 | 0.600 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 0.208502 | 0.681 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 0.195814 | 0.708 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 0.424153 | 0.372 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 0.349710 | 0.456 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 0.542342 | 0.266 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 0.196774 | 0.706 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 0.540288 | 0.267 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 0.216267 | 0.665 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 0.185359 | 0.732 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 0.297263 | 0.527 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 0.353144 | 0.452 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 0.450151 | 0.347 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 0.309704 | 0.509 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 0.228565 | 0.641 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 0.297404 | 0.527 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 0.161191 | 0.793 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 0.309431 | 0.509 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 0.355182 | 0.450 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 0.584014 | 0.234 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 0.315231 | 0.501 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 0.190924 | 0.719 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 0.494857 | 0.306 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 0.327656 | 0.485 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 0.474177 | 0.324 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 0.250796 | 0.601 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 0.274843 | 0.561 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 0.391034 | 0.408 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 0.424153 | 0.372 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 0.275442 | 0.560 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 0.610284 | 0.214 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 0.605044 | 0.218 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 0.614463 | 0.212 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 0.256277 | 0.591 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 0.434406 | 0.362 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 0.255112 | 0.593 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 0.605044 | 0.218 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 0.605044 | 0.218 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 0.380263 | 0.420 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 0.155421 | 0.808 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 0.526128 | 0.279 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 0.376651 | 0.424 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 0.339753 | 0.469 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 0.528689 | 0.277 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 0.613388 | 0.212 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 0.279482 | 0.554 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 0.312879 | 0.505 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 0.126217 | 0.899 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 0.464977 | 0.333 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 0.323626 | 0.490 | 0 | 0 |
| SLC-mediated bile acid transport | R-HSA-9958517 | 0.399818 | 0.398 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 0.357453 | 0.447 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 0.391034 | 0.408 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 0.527897 | 0.277 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 0.456625 | 0.340 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 0.380263 | 0.420 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 0.583421 | 0.234 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 0.514093 | 0.289 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 0.627224 | 0.203 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 0.274843 | 0.561 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 0.279586 | 0.553 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 0.279586 | 0.553 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 0.212026 | 0.674 | 1 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 0.453675 | 0.343 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 0.276175 | 0.559 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 0.239154 | 0.621 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 0.160626 | 0.794 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 0.144726 | 0.839 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 0.601483 | 0.221 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 0.310356 | 0.508 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 0.483478 | 0.316 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 0.346057 | 0.461 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 0.522518 | 0.282 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 0.581894 | 0.235 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 0.294782 | 0.530 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 0.163798 | 0.786 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 0.493798 | 0.306 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 0.218552 | 0.660 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 0.191317 | 0.718 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 0.126383 | 0.898 | 0 | 0 |
| Anchoring fibril formation | R-HSA-2214320 | 0.289802 | 0.538 | 0 | 0 |
| The NLRP1 inflammasome | R-HSA-844455 | 0.464977 | 0.333 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 0.527897 | 0.277 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 0.527897 | 0.277 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 0.294782 | 0.530 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 0.436652 | 0.360 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 0.488296 | 0.311 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 0.522518 | 0.282 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 0.408078 | 0.389 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 0.627224 | 0.203 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 0.256262 | 0.591 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 0.549460 | 0.260 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 0.434406 | 0.362 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 0.577353 | 0.239 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 0.256262 | 0.591 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 0.471726 | 0.326 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 0.497903 | 0.303 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 0.376664 | 0.424 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 0.146495 | 0.834 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 0.347157 | 0.459 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 0.204187 | 0.690 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 0.548751 | 0.261 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 0.622802 | 0.206 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 0.542342 | 0.266 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 0.483478 | 0.316 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 0.631012 | 0.200 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 0.631012 | 0.200 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 0.631012 | 0.200 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 0.631451 | 0.200 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 0.632418 | 0.199 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 0.632418 | 0.199 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 0.632418 | 0.199 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 0.632418 | 0.199 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 0.632418 | 0.199 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 0.632418 | 0.199 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 0.632418 | 0.199 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 0.632418 | 0.199 | 0 | 0 |
| Signaling by RNF43 mutants | R-HSA-5340588 | 0.632418 | 0.199 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 0.632418 | 0.199 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 0.632418 | 0.199 | 0 | 0 |
| Synthesis of dolichyl-phosphate mannose | R-HSA-162699 | 0.632418 | 0.199 | 0 | 0 |
| Sensory perception of salty taste | R-HSA-9730628 | 0.632418 | 0.199 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 0.632418 | 0.199 | 0 | 0 |
| VEGF binds to VEGFR leading to receptor dimerization | R-HSA-195399 | 0.632418 | 0.199 | 0 | 0 |
| VEGF ligand-receptor interactions | R-HSA-194313 | 0.632418 | 0.199 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 0.632418 | 0.199 | 0 | 0 |
| Relaxin receptors | R-HSA-444821 | 0.632418 | 0.199 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 0.632418 | 0.199 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 0.632418 | 0.199 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 0.632418 | 0.199 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 0.634049 | 0.198 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 0.634049 | 0.198 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 0.636870 | 0.196 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 0.636870 | 0.196 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 0.636870 | 0.196 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 0.636870 | 0.196 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 0.637645 | 0.195 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 0.639698 | 0.194 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 0.643281 | 0.192 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 0.645094 | 0.190 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 0.647098 | 0.189 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 0.647098 | 0.189 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 0.648090 | 0.188 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 0.648232 | 0.188 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 0.648232 | 0.188 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 0.649766 | 0.187 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 0.654101 | 0.184 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 0.654101 | 0.184 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 0.654101 | 0.184 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 0.655220 | 0.184 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 0.656005 | 0.183 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 0.656005 | 0.183 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 0.656005 | 0.183 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 0.656995 | 0.182 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 0.657916 | 0.182 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 0.657916 | 0.182 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 0.657916 | 0.182 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 0.657916 | 0.182 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 0.657916 | 0.182 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 0.660752 | 0.180 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 0.660752 | 0.180 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 0.661855 | 0.179 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 0.661855 | 0.179 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 0.662440 | 0.179 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 0.667093 | 0.176 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 0.667149 | 0.176 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 0.667149 | 0.176 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 0.667149 | 0.176 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 0.667740 | 0.175 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 0.668371 | 0.175 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 0.675654 | 0.170 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 0.675654 | 0.170 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 0.675654 | 0.170 | 0 | 0 |
| Metabolism of ingested MeSeO2H into MeSeH | R-HSA-5263617 | 0.675654 | 0.170 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 0.675654 | 0.170 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 0.675654 | 0.170 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 0.675654 | 0.170 | 0 | 0 |
| Intracellular metabolism of fatty acids regulates insulin secretion | R-HSA-434313 | 0.675654 | 0.170 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 0.675654 | 0.170 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 0.675654 | 0.170 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 0.675654 | 0.170 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 0.675654 | 0.170 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 0.675654 | 0.170 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 0.675654 | 0.170 | 0 | 0 |
| Defective factor VIII causes hemophilia A | R-HSA-9662001 | 0.675654 | 0.170 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 0.678966 | 0.168 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 0.679073 | 0.168 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 0.679073 | 0.168 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 0.679756 | 0.168 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 0.682288 | 0.166 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 0.683976 | 0.165 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 0.686549 | 0.163 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 0.686549 | 0.163 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 0.686549 | 0.163 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 0.686549 | 0.163 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 0.686549 | 0.163 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 0.686549 | 0.163 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 0.686549 | 0.163 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 0.686549 | 0.163 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 0.686549 | 0.163 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 0.686796 | 0.163 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 0.686796 | 0.163 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 0.687659 | 0.163 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 0.691668 | 0.160 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 0.691668 | 0.160 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 0.695559 | 0.158 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 0.695842 | 0.157 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 0.698703 | 0.156 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 0.698703 | 0.156 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 0.698703 | 0.156 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 0.698703 | 0.156 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 0.702266 | 0.153 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 0.702266 | 0.153 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 0.702266 | 0.153 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 0.702266 | 0.153 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 0.702266 | 0.153 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 0.702266 | 0.153 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 0.702266 | 0.153 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 0.706339 | 0.151 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 0.708571 | 0.150 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 0.713180 | 0.147 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 0.713180 | 0.147 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 0.713180 | 0.147 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 0.713180 | 0.147 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 0.713807 | 0.146 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 0.713807 | 0.146 | 0 | 0 |
| Glycoprotein hormones | R-HSA-209822 | 0.713807 | 0.146 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 0.713807 | 0.146 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 0.713807 | 0.146 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 0.713807 | 0.146 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 0.713807 | 0.146 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 0.713807 | 0.146 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 0.713807 | 0.146 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 0.713807 | 0.146 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 0.713807 | 0.146 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 0.713807 | 0.146 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 0.713807 | 0.146 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 0.713807 | 0.146 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 0.715925 | 0.145 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 0.717254 | 0.144 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 0.717724 | 0.144 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 0.718761 | 0.143 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 0.723548 | 0.141 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 0.723548 | 0.141 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 0.723548 | 0.141 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 0.723548 | 0.141 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 0.724661 | 0.140 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 0.727674 | 0.138 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 0.730845 | 0.136 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 0.732181 | 0.135 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 0.732181 | 0.135 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 0.732181 | 0.135 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 0.732501 | 0.135 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 0.734014 | 0.134 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 0.735715 | 0.133 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 0.738881 | 0.131 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 0.738975 | 0.131 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 0.739324 | 0.131 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 0.743622 | 0.129 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 0.743622 | 0.129 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 0.743622 | 0.129 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 0.743622 | 0.129 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 0.744252 | 0.128 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 0.745258 | 0.128 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 0.746327 | 0.127 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 0.747019 | 0.127 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 0.747473 | 0.126 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 0.747473 | 0.126 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 0.747473 | 0.126 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 0.747473 | 0.126 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 0.747473 | 0.126 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 0.747473 | 0.126 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 0.747473 | 0.126 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 0.747473 | 0.126 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 0.747473 | 0.126 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 0.747473 | 0.126 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 0.747473 | 0.126 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 0.747873 | 0.126 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 0.752827 | 0.123 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 0.752827 | 0.123 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 0.752827 | 0.123 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 0.752827 | 0.123 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 0.752827 | 0.123 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 0.757973 | 0.120 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 0.759532 | 0.119 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 0.759532 | 0.119 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 0.759696 | 0.119 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 0.759696 | 0.119 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 0.760751 | 0.119 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 0.760751 | 0.119 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 0.760751 | 0.119 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 0.762516 | 0.118 | 0 | 0 |
| Attachment of bacteria to epithelial cells | R-HSA-9638630 | 0.762516 | 0.118 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 0.762516 | 0.118 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 0.762516 | 0.118 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 0.766797 | 0.115 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 0.768792 | 0.114 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 0.769484 | 0.114 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 0.772920 | 0.112 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 0.772920 | 0.112 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 0.772920 | 0.112 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 0.772984 | 0.112 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 0.773383 | 0.112 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 0.773383 | 0.112 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 0.777182 | 0.109 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 0.777182 | 0.109 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 0.777182 | 0.109 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 0.777182 | 0.109 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 0.777182 | 0.109 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 0.777182 | 0.109 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 0.777182 | 0.109 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 0.777182 | 0.109 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 0.777182 | 0.109 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 0.777182 | 0.109 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 0.777182 | 0.109 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 0.777182 | 0.109 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 0.777186 | 0.109 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 0.777186 | 0.109 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 0.780263 | 0.108 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 0.780263 | 0.108 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 0.780263 | 0.108 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 0.780263 | 0.108 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 0.780263 | 0.108 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 0.780263 | 0.108 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 0.781865 | 0.107 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 0.781865 | 0.107 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 0.781865 | 0.107 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 0.781865 | 0.107 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 0.781865 | 0.107 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 0.782668 | 0.106 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 0.782710 | 0.106 | 1 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 0.785742 | 0.105 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 0.788907 | 0.103 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 0.790208 | 0.102 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 0.790827 | 0.102 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 0.790827 | 0.102 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 0.790827 | 0.102 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 0.796901 | 0.099 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 0.796901 | 0.099 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 0.798006 | 0.098 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 0.799036 | 0.097 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 0.799036 | 0.097 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 0.799036 | 0.097 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 0.801325 | 0.096 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 0.801325 | 0.096 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 0.801325 | 0.096 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 0.801325 | 0.096 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 0.801325 | 0.096 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 0.801325 | 0.096 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 0.801325 | 0.096 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 0.801325 | 0.096 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 0.803396 | 0.095 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 0.803396 | 0.095 | 0 | 0 |
| Peptide hormone biosynthesis | R-HSA-209952 | 0.803396 | 0.095 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 0.803396 | 0.095 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 0.803396 | 0.095 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 0.803396 | 0.095 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 0.803396 | 0.095 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 0.803396 | 0.095 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 0.803396 | 0.095 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 0.803396 | 0.095 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 0.803396 | 0.095 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 0.812472 | 0.090 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 0.812472 | 0.090 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 0.812472 | 0.090 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 0.812472 | 0.090 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 0.812797 | 0.090 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 0.812797 | 0.090 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 0.816794 | 0.088 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 0.817336 | 0.088 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 0.819226 | 0.087 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 0.819226 | 0.087 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 0.819226 | 0.087 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 0.819226 | 0.087 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 0.819226 | 0.087 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 0.819226 | 0.087 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 0.819226 | 0.087 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 0.819226 | 0.087 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 0.822643 | 0.085 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 0.825719 | 0.083 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 0.825775 | 0.083 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 0.826325 | 0.083 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 0.826528 | 0.083 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 0.826528 | 0.083 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 0.826528 | 0.083 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 0.826528 | 0.083 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 0.826528 | 0.083 | 0 | 0 |
| Hormone ligand-binding receptors | R-HSA-375281 | 0.826528 | 0.083 | 0 | 0 |
| Regulation of gene expression in early pancreatic precursor cells | R-HSA-210747 | 0.826528 | 0.083 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 0.826528 | 0.083 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 0.826528 | 0.083 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 0.826528 | 0.083 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 0.826528 | 0.083 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 0.833888 | 0.079 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 0.834497 | 0.079 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 0.835667 | 0.078 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 0.835667 | 0.078 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 0.835667 | 0.078 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 0.839102 | 0.076 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 0.839458 | 0.076 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 0.840588 | 0.075 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 0.843609 | 0.074 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 0.846194 | 0.073 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 0.846626 | 0.072 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 0.846626 | 0.072 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 0.846940 | 0.072 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by WNT ligand antagonists | R-HSA-3772470 | 0.846940 | 0.072 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 0.846940 | 0.072 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 0.846940 | 0.072 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 0.846940 | 0.072 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 0.846940 | 0.072 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 0.846940 | 0.072 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 0.846940 | 0.072 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 0.846940 | 0.072 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 0.849428 | 0.071 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 0.849494 | 0.071 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 0.849494 | 0.071 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 0.854301 | 0.068 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 0.858846 | 0.066 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 0.859350 | 0.066 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 0.859350 | 0.066 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 0.860126 | 0.065 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 0.860292 | 0.065 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 0.864548 | 0.063 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 0.864548 | 0.063 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 0.864548 | 0.063 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 0.864548 | 0.063 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 0.864548 | 0.063 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 0.864548 | 0.063 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 0.864548 | 0.063 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 0.864950 | 0.063 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 0.864950 | 0.063 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 0.864950 | 0.063 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 0.864950 | 0.063 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 0.864950 | 0.063 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 0.864950 | 0.063 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 0.864950 | 0.063 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 0.864950 | 0.063 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 0.864950 | 0.063 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 0.864980 | 0.063 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 0.864980 | 0.063 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 0.864980 | 0.063 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 0.866519 | 0.062 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 0.866519 | 0.062 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 0.867758 | 0.062 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 0.868719 | 0.061 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 0.868719 | 0.061 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 0.868719 | 0.061 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 0.869146 | 0.061 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 0.870420 | 0.060 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 0.873301 | 0.059 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 0.875897 | 0.058 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 0.877172 | 0.057 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 0.877172 | 0.057 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 0.877172 | 0.057 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 0.880468 | 0.055 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 0.880843 | 0.055 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 0.880843 | 0.055 | 0 | 0 |
| IL-6-type cytokine receptor ligand interactions | R-HSA-6788467 | 0.880843 | 0.055 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 0.880843 | 0.055 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 0.880843 | 0.055 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 0.880843 | 0.055 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 0.882849 | 0.054 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 0.884248 | 0.053 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 0.885158 | 0.053 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 0.885879 | 0.053 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 0.886023 | 0.053 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 0.886023 | 0.053 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 0.886023 | 0.053 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 0.886023 | 0.053 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 0.886023 | 0.053 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 0.886317 | 0.052 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 0.886317 | 0.052 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 0.888701 | 0.051 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 0.888701 | 0.051 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 0.888701 | 0.051 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 0.888701 | 0.051 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 0.888701 | 0.051 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 0.891905 | 0.050 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 0.892710 | 0.049 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 0.893797 | 0.049 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 0.894866 | 0.048 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 0.894866 | 0.048 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 0.894866 | 0.048 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 0.894866 | 0.048 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 0.894866 | 0.048 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 0.894866 | 0.048 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 0.894866 | 0.048 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 0.895404 | 0.048 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 0.895404 | 0.048 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 0.895404 | 0.048 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 0.897089 | 0.047 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 0.897089 | 0.047 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 0.897089 | 0.047 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 0.899219 | 0.046 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 0.899219 | 0.046 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 0.899219 | 0.046 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 0.899219 | 0.046 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 0.900102 | 0.046 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 0.904085 | 0.044 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 0.904085 | 0.044 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 0.904085 | 0.044 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 0.904838 | 0.043 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 0.904838 | 0.043 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 0.907239 | 0.042 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 0.907239 | 0.042 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 0.907239 | 0.042 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 0.907239 | 0.042 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 0.907239 | 0.042 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 0.907239 | 0.042 | 0 | 0 |
| FASTK family proteins regulate processing and stability of mitochondrial RNAs | R-HSA-9837092 | 0.907239 | 0.042 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 0.907239 | 0.042 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 0.907239 | 0.042 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 0.907239 | 0.042 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 0.908804 | 0.042 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 0.908804 | 0.042 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 0.908804 | 0.042 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 0.908804 | 0.042 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 0.912066 | 0.040 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 0.912109 | 0.040 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 0.912109 | 0.040 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 0.912112 | 0.040 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 0.912169 | 0.040 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 0.913339 | 0.039 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 0.916362 | 0.038 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 0.917529 | 0.037 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 0.917529 | 0.037 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 0.917529 | 0.037 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 0.917529 | 0.037 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 0.918157 | 0.037 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 0.918157 | 0.037 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 0.918157 | 0.037 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 0.918157 | 0.037 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 0.918157 | 0.037 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 0.918157 | 0.037 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 0.918157 | 0.037 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 0.918157 | 0.037 | 0 | 0 |
| Mineralocorticoid biosynthesis | R-HSA-193993 | 0.918157 | 0.037 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 0.918157 | 0.037 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 0.919517 | 0.036 | 0 | 0 |
| Biofilm formation | R-HSA-9931953 | 0.919517 | 0.036 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 0.920137 | 0.036 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 0.920569 | 0.036 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 0.920887 | 0.036 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 0.921978 | 0.035 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 0.925069 | 0.034 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 0.925069 | 0.034 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 0.925069 | 0.034 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 0.925464 | 0.034 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 0.925464 | 0.034 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 0.926351 | 0.033 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 0.927790 | 0.033 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 0.927790 | 0.033 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 0.927790 | 0.033 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 0.927790 | 0.033 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 0.927790 | 0.033 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 0.927790 | 0.033 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 0.927790 | 0.033 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) | R-HSA-400511 | 0.927790 | 0.033 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 0.927790 | 0.033 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 0.927790 | 0.033 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 0.928737 | 0.032 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 0.928737 | 0.032 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 0.928737 | 0.032 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 0.931141 | 0.031 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 0.931597 | 0.031 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 0.932649 | 0.030 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 0.932649 | 0.030 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 0.932675 | 0.030 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 0.932675 | 0.030 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 0.932675 | 0.030 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 0.936290 | 0.029 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 0.936290 | 0.029 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 0.936290 | 0.029 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 0.936290 | 0.029 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 0.936290 | 0.029 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 0.936290 | 0.029 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 0.936290 | 0.029 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 0.936290 | 0.029 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 0.936290 | 0.029 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 0.936441 | 0.029 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 0.939221 | 0.027 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 0.941237 | 0.026 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 0.941237 | 0.026 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 0.941343 | 0.026 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 0.941343 | 0.026 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 0.942517 | 0.026 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 0.943779 | 0.025 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 0.943779 | 0.025 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 0.943779 | 0.025 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 0.943779 | 0.025 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 0.943790 | 0.025 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 0.943790 | 0.025 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 0.943790 | 0.025 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 0.943790 | 0.025 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 0.943790 | 0.025 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 0.943790 | 0.025 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 0.943790 | 0.025 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 0.945160 | 0.024 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 0.945160 | 0.024 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 0.946006 | 0.024 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 0.948067 | 0.023 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 0.948680 | 0.023 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 0.948680 | 0.023 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 0.949273 | 0.023 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 0.950408 | 0.022 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 0.950408 | 0.022 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 0.950408 | 0.022 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 0.950408 | 0.022 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 0.950408 | 0.022 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 0.950543 | 0.022 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 0.950543 | 0.022 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 0.951024 | 0.022 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 0.951907 | 0.021 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 0.953180 | 0.021 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 0.953180 | 0.021 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 0.953313 | 0.021 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 0.953419 | 0.021 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 0.954329 | 0.020 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 0.955419 | 0.020 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 0.955419 | 0.020 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 0.955419 | 0.020 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 0.956246 | 0.019 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 0.956246 | 0.019 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 0.956246 | 0.019 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 0.956246 | 0.019 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 0.956246 | 0.019 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 0.957026 | 0.019 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 0.957138 | 0.019 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 0.957310 | 0.019 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 0.958031 | 0.019 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 0.958117 | 0.019 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 0.959450 | 0.018 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 0.961095 | 0.017 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 0.961095 | 0.017 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 0.961398 | 0.017 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 0.961398 | 0.017 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 0.961455 | 0.017 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 0.962984 | 0.016 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 0.963222 | 0.016 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 0.963826 | 0.016 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 0.963826 | 0.016 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 0.963826 | 0.016 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 0.965943 | 0.015 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 0.965943 | 0.015 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 0.965943 | 0.015 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 0.965943 | 0.015 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 0.967740 | 0.014 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 0.967740 | 0.014 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 0.968079 | 0.014 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 0.968335 | 0.014 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 0.968488 | 0.014 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 0.969953 | 0.013 | 0 | 0 |
| Reactions specific to the complex N-glycan synthesis pathway | R-HSA-975578 | 0.969953 | 0.013 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 0.969953 | 0.013 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 0.969953 | 0.013 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 0.969953 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 0.970231 | 0.013 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 0.970231 | 0.013 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 0.970551 | 0.013 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 0.970645 | 0.013 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 0.970645 | 0.013 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 0.970698 | 0.013 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 0.970698 | 0.013 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 0.971134 | 0.013 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 0.971435 | 0.013 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 0.972714 | 0.012 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 0.973394 | 0.012 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 0.973492 | 0.012 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 0.973492 | 0.012 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 0.973643 | 0.012 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 0.973643 | 0.012 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 0.974683 | 0.011 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 0.974815 | 0.011 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 0.975003 | 0.011 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 0.975728 | 0.011 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 0.976130 | 0.010 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 0.976301 | 0.010 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 0.976301 | 0.010 | 0 | 0 |
| Depurination | R-HSA-73927 | 0.976301 | 0.010 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 0.976376 | 0.010 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 0.976613 | 0.010 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 0.976613 | 0.010 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 0.977428 | 0.010 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 0.977945 | 0.010 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 0.977945 | 0.010 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 0.978699 | 0.009 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 0.978699 | 0.009 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 0.978699 | 0.009 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 0.979368 | 0.009 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 0.979368 | 0.009 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 0.979368 | 0.009 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 0.979368 | 0.009 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 0.979638 | 0.009 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 0.979648 | 0.009 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 0.979648 | 0.009 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 0.979654 | 0.009 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 0.980009 | 0.009 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 0.980861 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 0.980861 | 0.008 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 0.980861 | 0.008 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 0.980885 | 0.008 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 0.981070 | 0.008 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 0.981643 | 0.008 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 0.981798 | 0.008 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 0.981798 | 0.008 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 0.981798 | 0.008 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 0.981798 | 0.008 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 0.981812 | 0.008 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 0.982421 | 0.008 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 0.982472 | 0.008 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 0.982809 | 0.008 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 0.982809 | 0.008 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 0.982809 | 0.008 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 0.982809 | 0.008 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 0.982950 | 0.007 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 0.983306 | 0.007 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 0.983494 | 0.007 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 0.983942 | 0.007 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 0.983942 | 0.007 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 0.983942 | 0.007 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 0.983942 | 0.007 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 0.983942 | 0.007 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 0.983942 | 0.007 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 0.983978 | 0.007 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 0.984564 | 0.007 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 0.984564 | 0.007 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 0.984564 | 0.007 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 0.985360 | 0.006 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 0.985833 | 0.006 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 0.985833 | 0.006 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 0.985833 | 0.006 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 0.985833 | 0.006 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 0.986080 | 0.006 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 0.986080 | 0.006 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 0.986144 | 0.006 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 0.986144 | 0.006 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 0.986144 | 0.006 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 0.987502 | 0.005 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 0.987502 | 0.005 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 0.987502 | 0.005 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 0.987567 | 0.005 | 0 | 0 |
| Pyrimidine catabolism | R-HSA-73621 | 0.987567 | 0.005 | 0 | 0 |
| Protein folding | R-HSA-391251 | 0.987633 | 0.005 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 0.987633 | 0.005 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 0.987633 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 0.987793 | 0.005 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 0.987793 | 0.005 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 0.988644 | 0.005 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 0.988846 | 0.005 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 0.988846 | 0.005 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 0.988846 | 0.005 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 0.988847 | 0.005 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 0.988975 | 0.005 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 0.989388 | 0.005 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 0.989496 | 0.005 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 0.989897 | 0.004 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 0.989897 | 0.004 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 0.989997 | 0.004 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 0.989997 | 0.004 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 0.989997 | 0.004 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 0.990274 | 0.004 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 0.990274 | 0.004 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 0.990274 | 0.004 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 0.990274 | 0.004 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 0.990274 | 0.004 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 0.990852 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 0.990976 | 0.004 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 0.991138 | 0.004 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 0.991420 | 0.004 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 0.991719 | 0.004 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 0.991801 | 0.004 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 0.991961 | 0.004 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 0.992431 | 0.003 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 0.992431 | 0.003 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 0.992507 | 0.003 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 0.992796 | 0.003 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 0.993062 | 0.003 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 0.993085 | 0.003 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 0.993188 | 0.003 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 0.993323 | 0.003 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 0.993323 | 0.003 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 0.993323 | 0.003 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 0.993323 | 0.003 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 0.993323 | 0.003 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 0.993323 | 0.003 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 0.993546 | 0.003 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 0.993546 | 0.003 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 0.993784 | 0.003 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 0.994097 | 0.003 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 0.994109 | 0.003 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 0.994109 | 0.003 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 0.994109 | 0.003 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 0.994109 | 0.003 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 0.994109 | 0.003 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 0.994220 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 0.994294 | 0.002 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 0.994617 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 0.994710 | 0.002 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 0.994780 | 0.002 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 0.994804 | 0.002 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 0.994804 | 0.002 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 0.994804 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 0.994804 | 0.002 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 0.994804 | 0.002 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 0.995416 | 0.002 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 0.995416 | 0.002 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 0.995416 | 0.002 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 0.995476 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 0.995476 | 0.002 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 0.995636 | 0.002 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 0.995829 | 0.002 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 0.995914 | 0.002 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 0.995956 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 0.995956 | 0.002 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 0.995956 | 0.002 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 0.996379 | 0.002 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 0.996383 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 0.996428 | 0.002 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 0.996433 | 0.002 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 0.996433 | 0.002 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 0.996669 | 0.001 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 0.996680 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 0.996729 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 0.996853 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 0.996853 | 0.001 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 0.996853 | 0.001 | 0 | 0 |
| Diseases associated with N-glycosylation of proteins | R-HSA-3781860 | 0.996853 | 0.001 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 0.996962 | 0.001 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 0.996962 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 0.996994 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 0.996994 | 0.001 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 0.997030 | 0.001 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 0.997224 | 0.001 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 0.997224 | 0.001 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 0.997224 | 0.001 | 0 | 0 |
| N-glycan antennae elongation in the medial/trans-Golgi | R-HSA-975576 | 0.997224 | 0.001 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 0.997234 | 0.001 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 0.997288 | 0.001 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 0.997344 | 0.001 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 0.997344 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 0.997540 | 0.001 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 0.997552 | 0.001 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 0.997552 | 0.001 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 0.997729 | 0.001 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 0.997730 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 0.997877 | 0.001 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 0.997981 | 0.001 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 0.998048 | 0.001 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 0.998095 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 0.998102 | 0.001 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 0.998102 | 0.001 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 0.998146 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 0.998251 | 0.001 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 0.998300 | 0.001 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 0.998320 | 0.001 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 0.998518 | 0.001 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 0.998518 | 0.001 | 0 | 0 |
| Methylation | R-HSA-156581 | 0.998518 | 0.001 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 0.998518 | 0.001 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 0.998545 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 0.998545 | 0.001 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 0.998545 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 0.998548 | 0.001 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 0.998661 | 0.001 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 0.998692 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 0.998692 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 0.998728 | 0.001 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 0.998791 | 0.001 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 0.998847 | 0.001 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 0.998938 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 0.998938 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 0.998983 | 0.000 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 0.998983 | 0.000 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 0.998983 | 0.000 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 0.999003 | 0.000 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 0.999047 | 0.000 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 0.999047 | 0.000 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 0.999047 | 0.000 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 0.999053 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 0.999096 | 0.000 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 0.999103 | 0.000 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 0.999112 | 0.000 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 0.999124 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 0.999140 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 0.999232 | 0.000 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 0.999269 | 0.000 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 0.999384 | 0.000 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 0.999384 | 0.000 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 0.999384 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 0.999513 | 0.000 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 0.999521 | 0.000 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 0.999567 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 0.999584 | 0.000 | 1 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 0.999613 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 0.999627 | 0.000 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 0.999633 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 0.999655 | 0.000 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 0.999671 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 0.999713 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 0.999719 | 0.000 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 0.999753 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 0.999755 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 0.999761 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 0.999801 | 0.000 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 0.999801 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 0.999845 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 0.999878 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 0.999880 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 0.999880 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 0.999888 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 0.999893 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 0.999900 | 0.000 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 0.999913 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 0.999923 | 0.000 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 0.999945 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 0.999946 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 0.999947 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 0.999950 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 0.999956 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 0.999961 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 0.999962 | 0.000 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 0.999966 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 0.999969 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 0.999970 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 0.999970 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 0.999973 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 0.999982 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 0.999986 | 0.000 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 0.999987 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 0.999990 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 0.999993 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 0.999993 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 0.999993 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 0.999993 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 0.999994 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 0.999995 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 0.999995 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 0.999996 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 0.999997 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 0.999997 | 0.000 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 0.999997 | 0.000 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 0.999997 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 0.999997 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 0.999998 | 0.000 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 0.999998 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 0.999998 | 0.000 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 0.999998 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 0.999999 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 0.999999 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 0.999999 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 0.999999 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 0.999999 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 0.999999 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 1.000000 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 1.000000 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 1.000000 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 1.000000 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 1.000000 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 1.000000 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 1.000000 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 1.000000 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 1.000000 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 1.000000 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 1.000000 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000 | 0.000 | 1 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 1.000000 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 1.000000 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000 | 0.000 | 1 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 1.000000 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 1.000000 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000 | -0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000 | -0.000 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.000000 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin organization | R-HSA-4839726 | 4.715809e-07 | 6.326 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 9.825519e-07 | 6.008 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 1.044773e-06 | 5.981 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 1.044773e-06 | 5.981 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.481586e-06 | 5.829 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.955987e-06 | 5.305 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 8.823495e-06 | 5.054 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 7.601358e-06 | 5.119 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 9.363795e-06 | 5.029 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.942144e-06 | 5.003 | 1 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 4.200050e-05 | 4.377 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.419141e-05 | 4.266 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.895985e-05 | 4.103 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.054142e-04 | 3.977 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.222801e-04 | 3.913 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.332600e-04 | 3.875 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.742174e-04 | 3.759 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.947139e-04 | 3.711 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.112633e-04 | 3.675 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.322717e-04 | 3.634 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 3.079172e-04 | 3.512 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 3.165758e-04 | 3.500 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 4.047998e-04 | 3.393 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 4.336966e-04 | 3.363 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.278341e-04 | 3.369 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 3.792623e-04 | 3.421 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 4.035219e-04 | 3.394 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 4.624175e-04 | 3.335 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 5.348039e-04 | 3.272 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 5.348039e-04 | 3.272 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.865856e-04 | 3.163 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 7.461971e-04 | 3.127 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 8.205777e-04 | 3.086 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.164129e-03 | 2.934 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.369401e-03 | 2.863 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.450702e-03 | 2.838 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.522520e-03 | 2.817 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 1.561447e-03 | 2.806 | 1 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.656113e-03 | 2.781 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.090043e-03 | 2.680 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.140308e-03 | 2.670 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.267518e-03 | 2.644 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.421805e-03 | 2.616 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.743243e-03 | 2.562 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 2.816435e-03 | 2.550 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.131101e-03 | 2.504 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.131101e-03 | 2.504 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 3.056839e-03 | 2.515 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 3.211590e-03 | 2.493 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.630448e-03 | 2.440 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.630448e-03 | 2.440 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.648797e-03 | 2.438 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 3.446787e-03 | 2.463 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 3.467932e-03 | 2.460 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.600266e-03 | 2.444 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 3.554769e-03 | 2.449 | 1 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.830417e-03 | 2.417 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 3.888231e-03 | 2.410 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 4.130678e-03 | 2.384 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 4.037693e-03 | 2.394 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.188125e-03 | 2.378 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 4.232976e-03 | 2.373 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 4.808293e-03 | 2.318 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.808293e-03 | 2.318 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.774893e-03 | 2.321 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.515685e-03 | 2.345 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.301699e-03 | 2.276 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.495168e-03 | 2.260 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.473721e-03 | 2.262 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 5.159241e-03 | 2.287 | 1 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 5.629263e-03 | 2.250 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.486748e-03 | 2.261 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.066642e-03 | 2.295 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.632201e-03 | 2.249 | 1 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 5.495168e-03 | 2.260 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 6.253003e-03 | 2.204 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 6.645275e-03 | 2.177 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.086073e-03 | 2.150 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 7.347465e-03 | 2.134 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.284478e-03 | 2.082 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 8.779383e-03 | 2.057 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 8.995041e-03 | 2.046 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.460849e-03 | 2.073 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 9.546462e-03 | 2.020 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 9.882977e-03 | 2.005 | 1 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.007638e-02 | 1.997 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.007946e-02 | 1.997 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.007638e-02 | 1.997 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.224833e-02 | 1.912 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.224833e-02 | 1.912 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 1.162159e-02 | 1.935 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 1.158297e-02 | 1.936 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 1.123749e-02 | 1.949 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.123749e-02 | 1.949 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.125611e-02 | 1.949 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.197829e-02 | 1.922 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.223442e-02 | 1.912 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.125611e-02 | 1.949 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.224833e-02 | 1.912 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 1.234445e-02 | 1.909 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 1.235009e-02 | 1.908 | 1 | 1 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 1.241570e-02 | 1.906 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.261209e-02 | 1.899 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.261209e-02 | 1.899 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 1.252916e-02 | 1.902 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.269477e-02 | 1.896 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 1.371297e-02 | 1.863 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.294399e-02 | 1.888 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 1.252916e-02 | 1.902 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 1.252916e-02 | 1.902 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.390267e-02 | 1.857 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 1.395084e-02 | 1.855 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.412805e-02 | 1.850 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.412805e-02 | 1.850 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.430160e-02 | 1.845 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.430160e-02 | 1.845 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 1.589490e-02 | 1.799 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 1.589490e-02 | 1.799 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 1.589490e-02 | 1.799 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 1.538064e-02 | 1.813 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 1.538064e-02 | 1.813 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 1.538064e-02 | 1.813 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.645677e-02 | 1.784 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 1.555975e-02 | 1.808 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.517514e-02 | 1.819 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.613884e-02 | 1.792 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.742782e-02 | 1.759 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 1.816508e-02 | 1.741 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.816508e-02 | 1.741 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.816508e-02 | 1.741 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 1.866537e-02 | 1.729 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.866537e-02 | 1.729 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 1.882234e-02 | 1.725 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 1.882234e-02 | 1.725 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 1.932979e-02 | 1.714 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 2.037218e-02 | 1.691 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.037218e-02 | 1.691 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 2.241300e-02 | 1.649 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.241300e-02 | 1.649 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 2.394174e-02 | 1.621 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.139742e-02 | 1.670 | 1 | 0 |
| Developmental Biology | R-HSA-1266738 | 2.333562e-02 | 1.632 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.142950e-02 | 1.669 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 2.413478e-02 | 1.617 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.446907e-02 | 1.611 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 2.446907e-02 | 1.611 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.446907e-02 | 1.611 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.503078e-02 | 1.602 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.547135e-02 | 1.594 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.547135e-02 | 1.594 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.579369e-02 | 1.588 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.579369e-02 | 1.588 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 2.581790e-02 | 1.588 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 2.612550e-02 | 1.583 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.719847e-02 | 1.565 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 2.779983e-02 | 1.556 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.842981e-02 | 1.546 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 2.842981e-02 | 1.546 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.897540e-02 | 1.538 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.438801e-02 | 1.464 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.119139e-02 | 1.506 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.987275e-02 | 1.525 | 1 | 1 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 3.326811e-02 | 1.478 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 3.326811e-02 | 1.478 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 3.326811e-02 | 1.478 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.584088e-02 | 1.446 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.675492e-02 | 1.435 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.706509e-02 | 1.431 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.706509e-02 | 1.431 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 3.846104e-02 | 1.415 | 1 | 1 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.945529e-02 | 1.404 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 3.958066e-02 | 1.403 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 3.958066e-02 | 1.403 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 3.958066e-02 | 1.403 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 3.958066e-02 | 1.403 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 3.958066e-02 | 1.403 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 4.143541e-02 | 1.383 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.143541e-02 | 1.383 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 4.159259e-02 | 1.381 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.212521e-02 | 1.375 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 5.065168e-02 | 1.295 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 5.065168e-02 | 1.295 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.446469e-02 | 1.352 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.446469e-02 | 1.352 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.199273e-02 | 1.284 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 5.199273e-02 | 1.284 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 5.199273e-02 | 1.284 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.199273e-02 | 1.284 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 4.825777e-02 | 1.316 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.781737e-02 | 1.320 | 1 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 4.825777e-02 | 1.316 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 4.931728e-02 | 1.307 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 5.199273e-02 | 1.284 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.895727e-02 | 1.310 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.376187e-02 | 1.359 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 5.199273e-02 | 1.284 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 4.700997e-02 | 1.328 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 4.700997e-02 | 1.328 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 4.332809e-02 | 1.363 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.567337e-02 | 1.340 | 1 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.199273e-02 | 1.284 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 5.010025e-02 | 1.300 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 5.010025e-02 | 1.300 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.922146e-02 | 1.308 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.209429e-02 | 1.283 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.209429e-02 | 1.283 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 5.209429e-02 | 1.283 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 5.209429e-02 | 1.283 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.209429e-02 | 1.283 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.238391e-02 | 1.281 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 5.395809e-02 | 1.268 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.426242e-02 | 1.266 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.491303e-02 | 1.260 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 5.505695e-02 | 1.259 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.820453e-02 | 1.235 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.984076e-02 | 1.223 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 6.009242e-02 | 1.221 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.092935e-02 | 1.215 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.132855e-02 | 1.212 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 6.354617e-02 | 1.197 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.354921e-02 | 1.197 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.354921e-02 | 1.197 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 6.416037e-02 | 1.193 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 8.055791e-02 | 1.094 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.874326e-02 | 1.163 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 6.501183e-02 | 1.187 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 6.538250e-02 | 1.185 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 6.538250e-02 | 1.185 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 6.538250e-02 | 1.185 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.313071e-02 | 1.136 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 6.538250e-02 | 1.185 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.478162e-02 | 1.126 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 7.426351e-02 | 1.129 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 6.874326e-02 | 1.163 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.756841e-02 | 1.170 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 6.914112e-02 | 1.160 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 7.313071e-02 | 1.136 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 7.676160e-02 | 1.115 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 7.607858e-02 | 1.119 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.580437e-02 | 1.182 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 8.055791e-02 | 1.094 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 7.447116e-02 | 1.128 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 7.809588e-02 | 1.107 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 6.981046e-02 | 1.156 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 7.605470e-02 | 1.119 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 8.197001e-02 | 1.086 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.467673e-02 | 1.072 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.758275e-02 | 1.058 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 8.758275e-02 | 1.058 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.760556e-02 | 1.057 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 8.760556e-02 | 1.057 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 8.887995e-02 | 1.051 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 9.201889e-02 | 1.036 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.445414e-02 | 1.025 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 9.528746e-02 | 1.021 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.597034e-02 | 1.018 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 9.621430e-02 | 1.017 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.621430e-02 | 1.017 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 9.621430e-02 | 1.017 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 9.621430e-02 | 1.017 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 9.621430e-02 | 1.017 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 9.621430e-02 | 1.017 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.632442e-02 | 1.016 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.674918e-02 | 1.014 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.776643e-02 | 1.010 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.776643e-02 | 1.010 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 9.776643e-02 | 1.010 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 9.874067e-02 | 1.006 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 9.874067e-02 | 1.006 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.004348e-01 | 0.998 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 1.010393e-01 | 0.996 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 1.017013e-01 | 0.993 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 1.126445e-01 | 0.948 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 1.126445e-01 | 0.948 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.297301e-01 | 0.887 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 1.297301e-01 | 0.887 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 1.297301e-01 | 0.887 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 1.194123e-01 | 0.923 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 1.194123e-01 | 0.923 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.308408e-01 | 0.883 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 1.308408e-01 | 0.883 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.148734e-01 | 0.940 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.199362e-01 | 0.921 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.158997e-01 | 0.936 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.372037e-01 | 0.863 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.372037e-01 | 0.863 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.148734e-01 | 0.940 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 1.308408e-01 | 0.883 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 1.083780e-01 | 0.965 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.116080e-01 | 0.952 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.150806e-01 | 0.939 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.297301e-01 | 0.887 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 1.194123e-01 | 0.923 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.078474e-01 | 0.967 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.075018e-01 | 0.969 | 1 | 1 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.297301e-01 | 0.887 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.371508e-01 | 0.863 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.268004e-01 | 0.897 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.160018e-01 | 0.936 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.083780e-01 | 0.965 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 1.083780e-01 | 0.965 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.324138e-01 | 0.878 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 1.297301e-01 | 0.887 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 1.297301e-01 | 0.887 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 1.194123e-01 | 0.923 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.272885e-01 | 0.895 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.183915e-01 | 0.927 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.126445e-01 | 0.948 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.171380e-01 | 0.931 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.263520e-01 | 0.898 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.372037e-01 | 0.863 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.263448e-01 | 0.898 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.116080e-01 | 0.952 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.426348e-01 | 0.846 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.426348e-01 | 0.846 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 1.426348e-01 | 0.846 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 1.443965e-01 | 0.840 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 1.443965e-01 | 0.840 | 0 | 0 |
| Defective MMADHC causes MMAHCD | R-HSA-3359473 | 1.443965e-01 | 0.840 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 1.443965e-01 | 0.840 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 1.443965e-01 | 0.840 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 1.443965e-01 | 0.840 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.473629e-01 | 0.832 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.473629e-01 | 0.832 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 1.473629e-01 | 0.832 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.475905e-01 | 0.831 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.475905e-01 | 0.831 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.484062e-01 | 0.829 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.496997e-01 | 0.825 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.516687e-01 | 0.819 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.530721e-01 | 0.815 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 1.536080e-01 | 0.814 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.877421e-01 | 0.726 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 1.877421e-01 | 0.726 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 1.877421e-01 | 0.726 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 1.877421e-01 | 0.726 | 0 | 0 |
| Defective MMACHC causes MAHCC | R-HSA-3359474 | 2.288943e-01 | 0.640 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 2.288943e-01 | 0.640 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 2.288943e-01 | 0.640 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 2.679639e-01 | 0.572 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 2.679639e-01 | 0.572 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 2.679639e-01 | 0.572 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.654437e-01 | 0.781 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.654437e-01 | 0.781 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.654437e-01 | 0.781 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.654437e-01 | 0.781 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 3.050562e-01 | 0.516 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.838820e-01 | 0.735 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 2.025954e-01 | 0.693 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 2.025954e-01 | 0.693 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.025954e-01 | 0.693 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.025954e-01 | 0.693 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.025954e-01 | 0.693 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.025954e-01 | 0.693 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.025954e-01 | 0.693 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 3.402712e-01 | 0.468 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 3.402712e-01 | 0.468 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 3.402712e-01 | 0.468 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 3.402712e-01 | 0.468 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.547655e-01 | 0.810 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 3.737038e-01 | 0.427 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 3.737038e-01 | 0.427 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 3.737038e-01 | 0.427 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.799218e-01 | 0.745 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 2.596694e-01 | 0.586 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.596694e-01 | 0.586 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 1.928908e-01 | 0.715 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 1.928908e-01 | 0.715 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.787989e-01 | 0.555 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.787989e-01 | 0.555 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 4.054440e-01 | 0.392 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 4.054440e-01 | 0.392 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 4.054440e-01 | 0.392 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 4.054440e-01 | 0.392 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 1.670605e-01 | 0.777 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 2.978921e-01 | 0.526 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.978921e-01 | 0.526 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 1.873790e-01 | 0.727 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 1.612806e-01 | 0.792 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.467357e-01 | 0.608 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.467357e-01 | 0.608 | 1 | 1 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.467357e-01 | 0.608 | 1 | 1 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 3.169038e-01 | 0.499 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.355775e-01 | 0.361 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 4.355775e-01 | 0.361 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.355775e-01 | 0.361 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 2.605597e-01 | 0.584 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 2.605597e-01 | 0.584 | 1 | 1 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 2.605597e-01 | 0.584 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 2.605597e-01 | 0.584 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 2.605597e-01 | 0.584 | 1 | 1 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.301313e-01 | 0.638 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.957710e-01 | 0.708 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.681342e-01 | 0.774 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.681342e-01 | 0.774 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 2.047691e-01 | 0.689 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.641855e-01 | 0.333 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 2.139015e-01 | 0.670 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.909430e-01 | 0.719 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.636219e-01 | 0.579 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 3.730635e-01 | 0.428 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 2.325361e-01 | 0.634 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.420220e-01 | 0.616 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 3.447534e-01 | 0.462 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.481994e-01 | 0.605 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 3.095047e-01 | 0.509 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 3.588025e-01 | 0.445 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.588025e-01 | 0.445 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.653987e-01 | 0.576 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 2.653987e-01 | 0.576 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.435342e-01 | 0.613 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 3.728077e-01 | 0.429 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 4.272660e-01 | 0.369 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 4.272660e-01 | 0.369 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 3.560712e-01 | 0.448 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.793849e-01 | 0.421 | 1 | 1 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 3.910131e-01 | 0.408 | 1 | 1 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.910131e-01 | 0.408 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 4.416421e-01 | 0.355 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.416421e-01 | 0.355 | 1 | 1 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.484999e-01 | 0.348 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.484999e-01 | 0.348 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 4.115540e-01 | 0.386 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 3.048755e-01 | 0.516 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.416421e-01 | 0.355 | 1 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 2.313361e-01 | 0.636 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 2.313361e-01 | 0.636 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 2.340129e-01 | 0.631 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 2.744798e-01 | 0.561 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.978336e-01 | 0.704 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.978336e-01 | 0.704 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 2.744798e-01 | 0.561 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.978336e-01 | 0.704 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.397229e-01 | 0.620 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.416421e-01 | 0.355 | 1 | 1 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.457337e-01 | 0.461 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.979402e-01 | 0.526 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 3.007780e-01 | 0.522 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 4.550776e-01 | 0.342 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.782097e-01 | 0.749 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.165924e-01 | 0.499 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.884731e-01 | 0.540 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.917280e-01 | 0.535 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.672040e-01 | 0.777 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 4.272660e-01 | 0.369 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.301313e-01 | 0.638 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.411812e-01 | 0.618 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 3.165924e-01 | 0.499 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 4.280799e-01 | 0.368 | 1 | 1 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.588025e-01 | 0.445 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 3.050562e-01 | 0.516 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 4.355775e-01 | 0.361 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 4.641855e-01 | 0.333 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.867527e-01 | 0.413 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 1.550729e-01 | 0.809 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 1.550729e-01 | 0.809 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 3.482795e-01 | 0.458 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.330317e-01 | 0.633 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.782097e-01 | 0.749 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 2.523492e-01 | 0.598 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.598080e-01 | 0.337 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.978229e-01 | 0.704 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.313361e-01 | 0.636 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 2.710549e-01 | 0.567 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.910131e-01 | 0.408 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 3.444059e-01 | 0.463 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 2.025954e-01 | 0.693 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 3.050562e-01 | 0.516 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 3.050562e-01 | 0.516 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 2.787989e-01 | 0.555 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 2.787989e-01 | 0.555 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 2.978921e-01 | 0.526 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.884731e-01 | 0.540 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.038313e-01 | 0.394 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.165924e-01 | 0.499 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 3.566768e-01 | 0.448 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.331983e-01 | 0.363 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.654437e-01 | 0.781 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 3.728077e-01 | 0.429 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.838820e-01 | 0.735 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.371183e-01 | 0.359 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 4.641855e-01 | 0.333 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.977874e-01 | 0.400 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 1.877421e-01 | 0.726 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 1.877421e-01 | 0.726 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 2.288943e-01 | 0.640 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 3.050562e-01 | 0.516 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.838820e-01 | 0.735 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.838820e-01 | 0.735 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.838820e-01 | 0.735 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.838820e-01 | 0.735 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 3.402712e-01 | 0.468 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.215088e-01 | 0.655 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 3.737038e-01 | 0.427 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 4.355775e-01 | 0.361 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 4.355775e-01 | 0.361 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.357931e-01 | 0.474 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.545238e-01 | 0.450 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.447534e-01 | 0.462 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.793849e-01 | 0.421 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.620052e-01 | 0.335 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 4.026095e-01 | 0.395 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 4.416421e-01 | 0.355 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 4.416421e-01 | 0.355 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.778066e-01 | 0.423 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 4.008063e-01 | 0.397 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 2.668924e-01 | 0.574 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 2.330317e-01 | 0.633 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 3.357931e-01 | 0.474 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.185831e-01 | 0.378 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.455195e-01 | 0.462 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.094583e-01 | 0.388 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.093218e-01 | 0.679 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.025176e-01 | 0.519 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 2.567599e-01 | 0.590 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 2.004900e-01 | 0.698 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 4.355775e-01 | 0.361 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.802477e-01 | 0.420 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.771859e-01 | 0.752 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.021211e-01 | 0.396 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 2.605597e-01 | 0.584 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.730635e-01 | 0.428 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.061934e-01 | 0.686 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 3.533901e-01 | 0.452 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.588025e-01 | 0.445 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 2.002525e-01 | 0.698 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 2.679639e-01 | 0.572 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 1.799218e-01 | 0.745 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 4.054440e-01 | 0.392 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 4.641855e-01 | 0.333 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.444059e-01 | 0.463 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.793849e-01 | 0.421 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 1.722009e-01 | 0.764 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.097061e-01 | 0.678 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 2.734233e-01 | 0.563 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.025954e-01 | 0.693 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 4.641855e-01 | 0.333 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.047691e-01 | 0.689 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.978921e-01 | 0.526 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 3.025176e-01 | 0.519 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 3.306773e-01 | 0.481 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 4.115540e-01 | 0.386 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.194724e-01 | 0.659 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.523492e-01 | 0.598 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 2.595739e-01 | 0.586 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 4.272660e-01 | 0.369 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 4.324549e-01 | 0.364 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 2.679639e-01 | 0.572 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.402712e-01 | 0.468 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 2.405541e-01 | 0.619 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 4.054440e-01 | 0.392 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.978921e-01 | 0.526 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 4.641855e-01 | 0.333 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 4.641855e-01 | 0.333 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 3.913834e-01 | 0.407 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 4.447872e-01 | 0.352 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.620052e-01 | 0.335 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.620052e-01 | 0.335 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 3.934603e-01 | 0.405 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.780392e-01 | 0.749 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.867527e-01 | 0.413 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 2.134836e-01 | 0.671 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 4.447872e-01 | 0.352 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 3.190964e-01 | 0.496 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 1.654437e-01 | 0.781 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.067701e-01 | 0.685 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 3.913834e-01 | 0.407 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.006224e-01 | 0.397 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 3.805105e-01 | 0.420 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.867527e-01 | 0.413 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.978921e-01 | 0.526 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.956509e-01 | 0.709 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.327490e-01 | 0.478 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 4.096849e-01 | 0.388 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.672040e-01 | 0.777 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 3.737038e-01 | 0.427 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 4.054440e-01 | 0.392 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 4.054440e-01 | 0.392 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 4.355775e-01 | 0.361 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.192126e-01 | 0.659 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 2.744798e-01 | 0.561 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 3.730635e-01 | 0.428 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 4.006224e-01 | 0.397 | 1 | 1 |
| G2/M Transition | R-HSA-69275 | 3.794141e-01 | 0.421 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.696622e-01 | 0.770 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.006230e-01 | 0.522 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.641855e-01 | 0.333 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.457639e-01 | 0.609 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.882795e-01 | 0.411 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 4.272660e-01 | 0.369 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 1.799218e-01 | 0.745 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 4.094583e-01 | 0.388 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 3.237771e-01 | 0.490 | 1 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.402712e-01 | 0.468 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.215088e-01 | 0.655 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 2.596694e-01 | 0.586 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.357931e-01 | 0.474 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 4.641855e-01 | 0.333 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.717441e-01 | 0.765 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 3.817908e-01 | 0.418 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.613997e-01 | 0.792 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 4.550776e-01 | 0.342 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.866286e-01 | 0.729 | 1 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.698574e-01 | 0.569 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.420220e-01 | 0.616 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.306773e-01 | 0.481 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 4.021211e-01 | 0.396 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.256707e-01 | 0.371 | 1 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 3.169038e-01 | 0.499 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 3.984416e-01 | 0.400 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.864301e-01 | 0.543 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 3.050562e-01 | 0.516 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.596694e-01 | 0.586 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 4.280799e-01 | 0.368 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 2.243854e-01 | 0.649 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 1.873790e-01 | 0.727 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.327490e-01 | 0.478 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 4.256707e-01 | 0.371 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 2.787989e-01 | 0.555 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.997158e-01 | 0.700 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.228958e-01 | 0.491 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 3.545238e-01 | 0.450 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 3.512644e-01 | 0.454 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.194724e-01 | 0.659 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 2.710549e-01 | 0.567 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.600953e-01 | 0.796 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 3.727502e-01 | 0.429 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 4.272660e-01 | 0.369 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.226740e-01 | 0.374 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 3.909106e-01 | 0.408 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.447872e-01 | 0.352 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 4.651380e-01 | 0.332 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 4.665993e-01 | 0.331 | 1 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.683758e-01 | 0.329 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.683758e-01 | 0.329 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.710353e-01 | 0.327 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.710353e-01 | 0.327 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.710353e-01 | 0.327 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.710353e-01 | 0.327 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.710353e-01 | 0.327 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.710353e-01 | 0.327 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 4.723492e-01 | 0.326 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.733461e-01 | 0.325 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.773622e-01 | 0.321 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 4.789058e-01 | 0.320 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 4.789058e-01 | 0.320 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.815267e-01 | 0.317 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.815267e-01 | 0.317 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 4.819338e-01 | 0.317 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.821750e-01 | 0.317 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.821750e-01 | 0.317 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.823351e-01 | 0.317 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 4.907974e-01 | 0.309 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 4.913451e-01 | 0.309 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.913451e-01 | 0.309 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 4.913451e-01 | 0.309 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 4.913451e-01 | 0.309 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 4.913451e-01 | 0.309 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 4.913451e-01 | 0.309 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 4.913451e-01 | 0.309 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.913451e-01 | 0.309 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.913451e-01 | 0.309 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.913451e-01 | 0.309 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 4.913451e-01 | 0.309 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.945215e-01 | 0.306 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 4.954768e-01 | 0.305 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 4.954768e-01 | 0.305 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.978484e-01 | 0.303 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 5.020248e-01 | 0.299 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 5.041666e-01 | 0.297 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.073517e-01 | 0.295 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 5.073517e-01 | 0.295 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.117084e-01 | 0.291 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 5.117084e-01 | 0.291 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.117084e-01 | 0.291 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 5.117084e-01 | 0.291 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.117084e-01 | 0.291 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 5.150066e-01 | 0.288 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.171296e-01 | 0.286 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 5.171296e-01 | 0.286 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 5.171296e-01 | 0.286 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 5.171296e-01 | 0.286 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.171296e-01 | 0.286 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 5.200100e-01 | 0.284 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.243859e-01 | 0.280 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 5.257356e-01 | 0.279 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 5.257356e-01 | 0.279 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.299295e-01 | 0.276 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 5.300476e-01 | 0.276 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.397319e-01 | 0.268 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 5.416085e-01 | 0.266 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 5.416085e-01 | 0.266 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 5.416085e-01 | 0.266 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.416085e-01 | 0.266 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.416085e-01 | 0.266 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.416085e-01 | 0.266 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.431221e-01 | 0.265 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.431221e-01 | 0.265 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.431221e-01 | 0.265 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 5.431221e-01 | 0.265 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 5.447842e-01 | 0.264 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.468104e-01 | 0.262 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.468412e-01 | 0.262 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.468412e-01 | 0.262 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 5.534579e-01 | 0.257 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 5.568885e-01 | 0.254 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 5.577249e-01 | 0.254 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 5.582929e-01 | 0.253 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 5.582929e-01 | 0.253 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.582929e-01 | 0.253 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.648479e-01 | 0.248 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.648479e-01 | 0.248 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 5.648479e-01 | 0.248 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 5.648479e-01 | 0.248 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 5.648479e-01 | 0.248 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.648479e-01 | 0.248 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.648479e-01 | 0.248 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 5.648479e-01 | 0.248 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 5.648479e-01 | 0.248 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 5.648479e-01 | 0.248 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.648479e-01 | 0.248 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 5.648479e-01 | 0.248 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 5.674478e-01 | 0.246 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 5.699906e-01 | 0.244 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 5.699906e-01 | 0.244 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 5.699906e-01 | 0.244 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.731011e-01 | 0.242 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 5.731011e-01 | 0.242 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.731011e-01 | 0.242 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.731011e-01 | 0.242 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 5.770994e-01 | 0.239 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.775542e-01 | 0.238 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.775542e-01 | 0.238 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 5.789518e-01 | 0.237 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 5.805074e-01 | 0.236 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.869105e-01 | 0.231 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.869105e-01 | 0.231 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.869105e-01 | 0.231 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.869105e-01 | 0.231 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 5.869105e-01 | 0.231 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 5.869105e-01 | 0.231 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 5.869105e-01 | 0.231 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.875250e-01 | 0.231 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.875446e-01 | 0.231 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 5.973571e-01 | 0.224 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.016222e-01 | 0.221 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.016222e-01 | 0.221 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 6.016222e-01 | 0.221 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.016222e-01 | 0.221 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 6.078557e-01 | 0.216 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 6.078557e-01 | 0.216 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 6.078557e-01 | 0.216 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 6.078557e-01 | 0.216 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 6.078557e-01 | 0.216 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 6.078557e-01 | 0.216 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 6.078557e-01 | 0.216 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.078557e-01 | 0.216 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.100165e-01 | 0.215 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 6.144062e-01 | 0.212 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 6.153340e-01 | 0.211 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.153340e-01 | 0.211 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 6.153340e-01 | 0.211 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.153340e-01 | 0.211 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.153340e-01 | 0.211 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.165946e-01 | 0.210 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.165946e-01 | 0.210 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.234488e-01 | 0.205 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 6.259955e-01 | 0.203 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.259955e-01 | 0.203 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.277401e-01 | 0.202 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.277401e-01 | 0.202 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 6.277401e-01 | 0.202 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 6.277401e-01 | 0.202 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.277401e-01 | 0.202 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 6.277401e-01 | 0.202 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 6.277401e-01 | 0.202 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 6.277401e-01 | 0.202 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 6.277401e-01 | 0.202 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 6.277401e-01 | 0.202 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 6.277401e-01 | 0.202 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 6.283287e-01 | 0.202 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 6.286807e-01 | 0.202 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.286807e-01 | 0.202 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.286807e-01 | 0.202 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 6.286807e-01 | 0.202 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 6.286807e-01 | 0.202 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 6.286807e-01 | 0.202 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.286807e-01 | 0.202 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.318877e-01 | 0.199 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.348453e-01 | 0.197 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 6.359552e-01 | 0.197 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 6.371476e-01 | 0.196 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 6.389476e-01 | 0.195 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 6.416643e-01 | 0.193 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 6.416643e-01 | 0.193 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 6.416643e-01 | 0.193 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.443521e-01 | 0.191 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.466174e-01 | 0.189 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 6.466174e-01 | 0.189 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 6.466174e-01 | 0.189 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.466174e-01 | 0.189 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.466174e-01 | 0.189 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.466174e-01 | 0.189 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.466174e-01 | 0.189 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.466174e-01 | 0.189 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.466174e-01 | 0.189 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.466174e-01 | 0.189 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 6.466174e-01 | 0.189 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.537514e-01 | 0.185 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 6.542871e-01 | 0.184 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.542871e-01 | 0.184 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 6.542871e-01 | 0.184 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 6.542871e-01 | 0.184 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 6.542871e-01 | 0.184 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 6.542871e-01 | 0.184 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.566493e-01 | 0.183 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 6.573517e-01 | 0.182 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 6.607283e-01 | 0.180 | 1 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.645385e-01 | 0.177 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.645385e-01 | 0.177 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.645385e-01 | 0.177 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.645385e-01 | 0.177 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 6.665523e-01 | 0.176 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 6.665523e-01 | 0.176 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 6.665523e-01 | 0.176 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 6.665523e-01 | 0.176 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.666739e-01 | 0.176 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 6.685364e-01 | 0.175 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 6.685364e-01 | 0.175 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 6.685364e-01 | 0.175 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.779257e-01 | 0.169 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 6.784639e-01 | 0.168 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.784639e-01 | 0.168 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.784639e-01 | 0.168 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 6.792477e-01 | 0.168 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 6.815518e-01 | 0.167 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 6.815518e-01 | 0.167 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 6.815518e-01 | 0.167 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 6.815518e-01 | 0.167 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.815518e-01 | 0.167 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 6.815518e-01 | 0.167 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 6.815518e-01 | 0.167 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.815518e-01 | 0.167 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.815518e-01 | 0.167 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 6.815518e-01 | 0.167 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 6.875878e-01 | 0.163 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 6.883622e-01 | 0.162 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 6.890889e-01 | 0.162 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 6.890889e-01 | 0.162 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 6.900260e-01 | 0.161 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 6.900260e-01 | 0.161 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 6.900260e-01 | 0.161 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 6.900260e-01 | 0.161 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 6.957736e-01 | 0.158 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 6.977032e-01 | 0.156 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 6.977032e-01 | 0.156 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.977032e-01 | 0.156 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 6.977032e-01 | 0.156 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 6.977032e-01 | 0.156 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 6.977032e-01 | 0.156 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 6.977032e-01 | 0.156 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 6.977032e-01 | 0.156 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 6.977032e-01 | 0.156 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 6.977032e-01 | 0.156 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 6.994420e-01 | 0.155 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.012435e-01 | 0.154 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 7.012435e-01 | 0.154 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 7.012435e-01 | 0.154 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.012435e-01 | 0.154 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.012435e-01 | 0.154 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 7.046244e-01 | 0.152 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.091150e-01 | 0.149 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.091150e-01 | 0.149 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 7.116317e-01 | 0.148 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 7.121215e-01 | 0.147 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 7.121215e-01 | 0.147 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 7.121215e-01 | 0.147 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 7.121215e-01 | 0.147 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.130364e-01 | 0.147 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.130364e-01 | 0.147 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 7.130364e-01 | 0.147 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 7.130364e-01 | 0.147 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 7.130364e-01 | 0.147 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.130364e-01 | 0.147 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 7.130364e-01 | 0.147 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 7.130364e-01 | 0.147 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.135786e-01 | 0.147 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 7.135786e-01 | 0.147 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 7.135786e-01 | 0.147 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 7.194043e-01 | 0.143 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.223217e-01 | 0.141 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 7.226657e-01 | 0.141 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.226657e-01 | 0.141 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 7.226657e-01 | 0.141 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.226657e-01 | 0.141 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.226657e-01 | 0.141 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.236392e-01 | 0.140 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.275927e-01 | 0.138 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.275927e-01 | 0.138 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.275927e-01 | 0.138 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.275927e-01 | 0.138 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 7.275927e-01 | 0.138 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.275927e-01 | 0.138 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 7.275927e-01 | 0.138 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 7.328819e-01 | 0.135 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 7.328819e-01 | 0.135 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 7.343886e-01 | 0.134 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.414115e-01 | 0.130 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.414115e-01 | 0.130 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 7.414115e-01 | 0.130 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.414115e-01 | 0.130 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 7.414115e-01 | 0.130 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.414115e-01 | 0.130 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.414115e-01 | 0.130 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.414115e-01 | 0.130 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 7.414115e-01 | 0.130 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 7.416516e-01 | 0.130 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 7.427762e-01 | 0.129 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 7.427762e-01 | 0.129 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 7.427762e-01 | 0.129 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 7.427762e-01 | 0.129 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.464896e-01 | 0.127 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.464896e-01 | 0.127 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 7.487629e-01 | 0.126 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.523550e-01 | 0.124 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 7.523550e-01 | 0.124 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 7.523550e-01 | 0.124 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.528515e-01 | 0.123 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.545301e-01 | 0.122 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.545301e-01 | 0.122 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.545301e-01 | 0.122 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 7.545301e-01 | 0.122 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.545301e-01 | 0.122 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.545301e-01 | 0.122 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 7.545301e-01 | 0.122 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 7.616248e-01 | 0.118 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 7.616248e-01 | 0.118 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 7.616248e-01 | 0.118 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 7.616248e-01 | 0.118 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 7.616248e-01 | 0.118 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 7.616248e-01 | 0.118 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.616248e-01 | 0.118 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.616248e-01 | 0.118 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 7.621504e-01 | 0.118 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 7.669839e-01 | 0.115 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.669839e-01 | 0.115 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 7.669839e-01 | 0.115 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 7.669839e-01 | 0.115 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 7.704528e-01 | 0.113 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 7.704528e-01 | 0.113 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 7.705923e-01 | 0.113 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 7.705923e-01 | 0.113 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 7.705923e-01 | 0.113 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.742905e-01 | 0.111 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 7.757111e-01 | 0.110 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 7.771077e-01 | 0.110 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.777745e-01 | 0.109 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.777745e-01 | 0.109 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 7.777745e-01 | 0.109 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 7.788066e-01 | 0.109 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.788066e-01 | 0.109 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.788066e-01 | 0.109 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 7.788066e-01 | 0.109 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.788066e-01 | 0.109 | 0 | 0 |
| Organic anion transport by SLCO transporters | R-HSA-879518 | 7.788066e-01 | 0.109 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 7.788066e-01 | 0.109 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.792643e-01 | 0.108 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 7.792643e-01 | 0.108 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 7.802417e-01 | 0.108 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 7.849030e-01 | 0.105 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 7.900301e-01 | 0.102 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 7.900301e-01 | 0.102 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.900301e-01 | 0.102 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 7.900301e-01 | 0.102 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 7.900301e-01 | 0.102 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.918414e-01 | 0.101 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 7.943865e-01 | 0.100 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 7.957495e-01 | 0.099 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 7.957495e-01 | 0.099 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 8.006848e-01 | 0.097 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.006848e-01 | 0.097 | 0 | 0 |
| Defects in cobalamin (B12) metabolism | R-HSA-3296469 | 8.006848e-01 | 0.097 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.006848e-01 | 0.097 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.006848e-01 | 0.097 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 8.006848e-01 | 0.097 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.006848e-01 | 0.097 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.006848e-01 | 0.097 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 8.006848e-01 | 0.097 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.035765e-01 | 0.095 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 8.048048e-01 | 0.094 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 8.061280e-01 | 0.094 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.107994e-01 | 0.091 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 8.107994e-01 | 0.091 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.107994e-01 | 0.091 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 8.107994e-01 | 0.091 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.107994e-01 | 0.091 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.107994e-01 | 0.091 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 8.111359e-01 | 0.091 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.111359e-01 | 0.091 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 8.111359e-01 | 0.091 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.115451e-01 | 0.091 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.183189e-01 | 0.087 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 8.184345e-01 | 0.087 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 8.184345e-01 | 0.087 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 8.204013e-01 | 0.086 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.204013e-01 | 0.086 | 0 | 0 |
| Cobalamin (Cbl) metabolism | R-HSA-9759218 | 8.204013e-01 | 0.086 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.204013e-01 | 0.086 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.204013e-01 | 0.086 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 8.204013e-01 | 0.086 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.204013e-01 | 0.086 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 8.204013e-01 | 0.086 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 8.204013e-01 | 0.086 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 8.237863e-01 | 0.084 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.237863e-01 | 0.084 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 8.237863e-01 | 0.084 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.254795e-01 | 0.083 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.254795e-01 | 0.083 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 8.295165e-01 | 0.081 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.295165e-01 | 0.081 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.295165e-01 | 0.081 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.295165e-01 | 0.081 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.322777e-01 | 0.080 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 8.322777e-01 | 0.080 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.331035e-01 | 0.079 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.353420e-01 | 0.078 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.353420e-01 | 0.078 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.353420e-01 | 0.078 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 8.381061e-01 | 0.077 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.381696e-01 | 0.077 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 8.381696e-01 | 0.077 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 8.381696e-01 | 0.077 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.381696e-01 | 0.077 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 8.388360e-01 | 0.076 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 8.389135e-01 | 0.076 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.451613e-01 | 0.073 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 8.451613e-01 | 0.073 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.451613e-01 | 0.073 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.463839e-01 | 0.072 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 8.463839e-01 | 0.072 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.463839e-01 | 0.072 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.463839e-01 | 0.072 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 8.477348e-01 | 0.072 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.541818e-01 | 0.068 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 8.541818e-01 | 0.068 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 8.568754e-01 | 0.067 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.598750e-01 | 0.066 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 8.614089e-01 | 0.065 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.615843e-01 | 0.065 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.621972e-01 | 0.064 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.633506e-01 | 0.064 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 8.682655e-01 | 0.061 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.686115e-01 | 0.061 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 8.686115e-01 | 0.061 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 8.686115e-01 | 0.061 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 8.686115e-01 | 0.061 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 8.686115e-01 | 0.061 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 8.697081e-01 | 0.061 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.735248e-01 | 0.059 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 8.735248e-01 | 0.059 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 8.752491e-01 | 0.058 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.752823e-01 | 0.058 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 8.777028e-01 | 0.057 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 8.777028e-01 | 0.057 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.777028e-01 | 0.057 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 8.785902e-01 | 0.056 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 8.785902e-01 | 0.056 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 8.785902e-01 | 0.056 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.785902e-01 | 0.056 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.815480e-01 | 0.055 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.816148e-01 | 0.055 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 8.816148e-01 | 0.055 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.816148e-01 | 0.055 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.816148e-01 | 0.055 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.816148e-01 | 0.055 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.816148e-01 | 0.055 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.822454e-01 | 0.054 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.834678e-01 | 0.054 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 8.852691e-01 | 0.053 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.876261e-01 | 0.052 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.876261e-01 | 0.052 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 8.876261e-01 | 0.052 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.876261e-01 | 0.052 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.876261e-01 | 0.052 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.876261e-01 | 0.052 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.878503e-01 | 0.052 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 8.881634e-01 | 0.052 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 8.917908e-01 | 0.050 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 8.924244e-01 | 0.049 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 8.926831e-01 | 0.049 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.931151e-01 | 0.049 | 1 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.933325e-01 | 0.049 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.933325e-01 | 0.049 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.933325e-01 | 0.049 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 8.943192e-01 | 0.049 | 1 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.972148e-01 | 0.047 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 8.987495e-01 | 0.046 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 8.987495e-01 | 0.046 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.993014e-01 | 0.046 | 0 | 0 |
| Protein folding | R-HSA-391251 | 8.993014e-01 | 0.046 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.028778e-01 | 0.044 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.038917e-01 | 0.044 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.038917e-01 | 0.044 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.052432e-01 | 0.043 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.052432e-01 | 0.043 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 9.055695e-01 | 0.043 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 9.055695e-01 | 0.043 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.087730e-01 | 0.042 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 9.128387e-01 | 0.040 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.129288e-01 | 0.040 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.134067e-01 | 0.039 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.134067e-01 | 0.039 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.134067e-01 | 0.039 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 9.134067e-01 | 0.039 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 9.145926e-01 | 0.039 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.146887e-01 | 0.039 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.164188e-01 | 0.038 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.178053e-01 | 0.037 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.178053e-01 | 0.037 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.216262e-01 | 0.035 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 9.219807e-01 | 0.035 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.219807e-01 | 0.035 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.220254e-01 | 0.035 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.259443e-01 | 0.033 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 9.263471e-01 | 0.033 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.275980e-01 | 0.033 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.276608e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.297067e-01 | 0.032 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.323362e-01 | 0.030 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.328029e-01 | 0.030 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.332782e-01 | 0.030 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.332782e-01 | 0.030 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.332782e-01 | 0.030 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 9.332797e-01 | 0.030 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.351550e-01 | 0.029 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 9.362694e-01 | 0.029 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.366685e-01 | 0.028 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.366685e-01 | 0.028 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.368591e-01 | 0.028 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 9.376612e-01 | 0.028 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.378623e-01 | 0.028 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.378623e-01 | 0.028 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.401967e-01 | 0.027 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.401967e-01 | 0.027 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.404622e-01 | 0.027 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.429414e-01 | 0.026 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 9.429585e-01 | 0.026 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.430467e-01 | 0.025 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.443428e-01 | 0.025 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 9.443428e-01 | 0.025 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.453551e-01 | 0.024 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.458412e-01 | 0.024 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.464180e-01 | 0.024 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.484212e-01 | 0.023 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.484212e-01 | 0.023 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.485938e-01 | 0.023 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.498637e-01 | 0.022 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.500741e-01 | 0.022 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.500741e-01 | 0.022 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.504364e-01 | 0.022 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.507056e-01 | 0.022 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 9.507056e-01 | 0.022 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 9.513335e-01 | 0.022 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.536868e-01 | 0.021 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.536868e-01 | 0.021 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.557563e-01 | 0.020 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.557563e-01 | 0.020 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.560410e-01 | 0.020 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 9.560410e-01 | 0.020 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.582757e-01 | 0.019 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.596335e-01 | 0.018 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.624105e-01 | 0.017 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.643217e-01 | 0.016 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.643217e-01 | 0.016 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.645899e-01 | 0.016 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.661359e-01 | 0.015 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.669043e-01 | 0.015 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.675634e-01 | 0.014 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.678580e-01 | 0.014 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.689586e-01 | 0.014 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.689586e-01 | 0.014 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.689586e-01 | 0.014 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.694925e-01 | 0.013 | 0 | 0 |
| Kinesins | R-HSA-983189 | 9.710441e-01 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.710441e-01 | 0.013 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.715775e-01 | 0.013 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.729490e-01 | 0.012 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.733981e-01 | 0.012 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.736767e-01 | 0.012 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.751103e-01 | 0.011 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.751103e-01 | 0.011 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.767463e-01 | 0.010 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.772256e-01 | 0.010 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.775369e-01 | 0.010 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.791665e-01 | 0.009 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 9.800758e-01 | 0.009 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.809306e-01 | 0.008 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.809306e-01 | 0.008 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.828114e-01 | 0.008 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.828220e-01 | 0.008 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.836962e-01 | 0.007 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.853136e-01 | 0.006 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 9.853136e-01 | 0.006 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.853760e-01 | 0.006 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.860612e-01 | 0.006 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.867707e-01 | 0.006 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.867707e-01 | 0.006 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.871392e-01 | 0.006 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 9.871392e-01 | 0.006 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.878523e-01 | 0.005 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.885860e-01 | 0.005 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.886901e-01 | 0.005 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.898692e-01 | 0.004 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.907512e-01 | 0.004 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.929344e-01 | 0.003 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.929706e-01 | 0.003 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.936360e-01 | 0.003 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.942933e-01 | 0.002 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 9.943282e-01 | 0.002 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.945601e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.953501e-01 | 0.002 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.956098e-01 | 0.002 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.958121e-01 | 0.002 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.959589e-01 | 0.002 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.960256e-01 | 0.002 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.960256e-01 | 0.002 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.961421e-01 | 0.002 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.962282e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.962895e-01 | 0.002 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.966030e-01 | 0.001 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.967762e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.968797e-01 | 0.001 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.969427e-01 | 0.001 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.970725e-01 | 0.001 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.970966e-01 | 0.001 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.971035e-01 | 0.001 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.973448e-01 | 0.001 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.973852e-01 | 0.001 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 9.979190e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.979930e-01 | 0.001 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.982533e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.982800e-01 | 0.001 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.985598e-01 | 0.001 | 1 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.988080e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.988080e-01 | 0.001 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.988888e-01 | 0.000 | 1 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.989246e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.989266e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.990466e-01 | 0.000 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.990876e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.992596e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.993645e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.994002e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.994671e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.995361e-01 | 0.000 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.995581e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.996787e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.997337e-01 | 0.000 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.997907e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998035e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998418e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999262e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999379e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.999564e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.999564e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999648e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999665e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999709e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999755e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999787e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999848e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999900e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 9.999972e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999978e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999995e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.999998e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999999e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 1.000000e+00 | 0.000 | 1 | 1 |